Severe malaria in children Glucose homeostasis and laboratory indicators of patients at risk by Mohammed, Mona
 1
Graduate college 
Medical and health studies board 
 
Severe malaria in children 
Glucose homeostasis and laboratory indicators of patients at risk  
(M. Sc) 
A thesis submitted in fulfillment for the requirements of the degree in M. Sc in Human 
Physiology 
 
 
By 
Mona Mohammed Ali Elamin 
Faculty of Medicine 
B. Sc Honour 
University of Khartoum 
 
 
 
 
 
 
 
 
Supervisor 
  Prof. M.Y. Sukkar 
Department of   Physiology 
Faculty of Medicine 
University of Khartoum 
 
May 2009 
 
 
 
 2
 
 
 
 
 
 
 
 
Dedications 
To my father 
 3
Mother 
Husband 
Sisters 
And my brother 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 
I would like to express my thanks and gratitude to Professor Mohammed Yousif 
Sukkar, Department of physiology, Faculty of medicine, University of Khartoum, for his 
supervising this work and providing me with the unique opportunity to work with him. I 
 4
do appreciate his assistance, encouragement, continuous support, endless supervision and 
valuable suggestions during this study. 
 
I wish to thank Dr Amar El taher head department of physiology, Faculty of medicine, 
University of Khartoum during the course of the study, for his assistance and facilities to 
work in Khartoum Paediatric Hospital. I also like to thank Dr Amal Mahmoud Saeed 
Department of physiology, Faculty of medicine, University of Khartoum, for her 
unlimited support and encouragement. I would also like to thank all the staff of 
physiology department, Faculty of medicine, University of Khartoum. 
 
My thanks and deep gratitude to the staff of Khartoum Paediatric and Bashaeir Hospitals,  
especially to the staff of Khartoum Paediatric Hospitals Lab for offering me a space at 
their lab and for their effort in obtaining the consent  the patients to take part in this 
study. I would also like to thank the medical staff in the hospitals for their help to identify 
the cases and undertaking the clinical examinations. 
 
I am very grateful to the Ministry of Higher Education. This work would have never been 
done without the financial support of the Ministry of Higher Education and Scientific 
Research. 
Deep gratitude and thanks to Dr Nagei Ibrahim and Dr Deana Ahmed Hassan, for their 
assistance and support with RIA and amino acids analysis. My special thanks to Adel 
Amin for his help with the in statistical analysis. 
 I am very indebted to all my friends and colleagues and for all those I did not mention 
"Thank you for your moral support".  
 
 5
    
Table of contents 
 
I Dedication 
II Acknowledgements 
VI Abbreviations 
VII List of tables 
VIII List of figures 
IX Abstract 
XII Arabic abstract 
1 Introduction 
4 CHAPTER ONE: LITERATURE REVIEW 
4 Life Cycle of the Malaria Parasite 
5 Antimalarial Drugs 
5 Clinical Picture of Malaria 
6 Uncomplicated Malaria 
7 Severe Falciparum Malaria 
8              Studies of Severe Malaria in African Children 
9 Pathophysiology of Severe Malaria 
9              Sequestration of Parasitized Red Blood Cells 
11 Features of Severe Malaria in Children 
11               Cerebral malaria 
14               Seizure 
14               Severe Anaemia 
15               Hypotension/shock 
16               Fever 
16               Hyperparasitaemia 
17               Jaundice 
17               Renal failure 
18               Electrolyte Abnormalities 
18               Metabolic Acidosis 
20               Hypoglycaemia 
24 Amino Acids Changes in Malaria 
25              Arginine 
28              Glutamine 
28              Phenylalanine 
29              Large Neutral Amino Acids (NAA)
30 Aminergic System in the Brain 
30              The Reticular Formation
30              Biosynthesis and Release of Catecholamine
32 Glucose Homeostasis 
33              Factors Affecting Hepatic Production
34              Glucoregulatory Hormones
38 The Objectives of the Study 
39 CHAPTER TWO: PATIENTS AND METHODS 
39 Location and Time of the Study 
39 Patients and Controls 
39 History and Physical Examination 
 6
39 Laboratory Analyses 
39           Blood Samples 
40           Malaria Diagnosis 
40           Haemoglobin Estimations 
41           Potassium Measurement 
41           Random Blood Glucose Measurement 
42          Amino Acid Analysis 
44          Measurements of Insulin and C-peptide  
46 CHAPTER THREE: RESULT 
46 The Frequency Distribution of Severe and Uncomplicated Malaria 
49 Characterization and Grouping of Patients with Severe Malaria 
50 Investigations in the Severe and Uncomplicated Malaria 
50         Blood Glucose  
52         Insulin 
54         C-peptide 
55         Insulin: C-peptide Ratio
56         Correlation Between RBG and Insulin 
58         Correlation Between Insulin and C-peptide 
59         Potassium 
61         Blood Urea Nitrogen 
62         Haemoglobin 
63         Amino Acids Results 
64         Amino Acids in Categories of the Severe Malaria 
69         Glucogenic Plasma Amino Acids Levels 
71         Large Neutral Amino Acid Levels 
72        Results of Jaundice Cases
72         Fatality Cases in the Study 
73 CHAPTER FOUR: DISSCUSION 
73 Age Distribution of the Disease 
73 Glucose Homeostasis 
73         Random Blood Glucose 
74         Insulin:C-peptide Ratio 
75         Hypoglycaemia 
77         Cerebral Malaria 
78 Serum Electrolytes and Urea
78         Potassium 
79         Urea 
80 Amino Acids in Severe and Uncomplicated Malaria 
81        Arginine 
84        Citrulline 
84         Ornithine 
85         Phenylalanine 
86         Amino Acids in the Three Main Categories of Severe malaria
90 Conclusions 
93 Recommendation 
94 References 
109 Appendix I Data collection form 
112 Appendix II Buffer composition 
 7
Abbreviations 
 
P.f :  Plasmodium falciparum 
CM: Cerebral malaria 
NO: Nitric oxide 
NOS: Nitric oxide synthase 
CNS: Central nervous system 
RBC: Red blood cells 
pRBC: parasitized red blood cells 
Hb: haemoglobin 
RBG: Random blood glucose 
I:C: Insulin C-peptide ratio 
LNAA: Large neutral amino acids 
BBB: Blood brain barrier 
BUN: Blood urea nitrogen 
RIA: Radioimmunoassay  
 
Amino acids 
Tau: Taurine 
Ser: Serine 
Thr: Threonine 
Asn: Asparagine 
Gly: Glycine 
Ala: Alanine 
Cit: Citrulline 
Val: Valine 
Cys: Cysteine 
Met: Methionine 
Ile: Isoleucine 
Leu: Leucine 
Tyr: Tyrosine 
Phe: Phenylalanine 
Lys: Lysine 
His: Histidine 
Trp: Tryptophane 
Arg: Arginine 
Orn: Ornithine 
Asp: Aspartate 
Glu: Glutamate 
 
 
 
 
 
 8
List of tables 
 
 
46 Table (1): Sample characteristics 
47 Table (2): The Mean Age of the different categories of patients with severe malaria 
48 Table (3): Presenting features of children with Plasmodium falciparum malaria in descending order of frequency 
50 Table (4): Means of RBG, insulin, C-peptide, K
+ and Hb in patients of severe 
& uncomplicated malaria 
51 Table (5): Comparison of RBG between uncomplicated malaria and the clinical categories of the severe malaria 
53 Table (6): Comparison of insulin between uncomplicated malaria and the clinical categories of the severe malaria 
55 Table (7):  Comparison of C-peptide between uncomplicated malaria and the clinical categories of the severe malaria 
55 Table (8): Means of Insulin: C-peptide ratio in the severe and uncomplicated malaria 
56 Table (9): Comparison of Insulin: C-peptide ratio between uncomplicated malaria and the clinical categories of the severe malaria 
60 Table (10): Comparison of Potassium between uncomplicated malaria and the clinical categories of the severe malaria 
61 Table (11): Means of BUN in the severe and uncomplicated malaria 
61 Table (12): Comparison of BUN between uncomplicated malaria and the clinical categories of the severe malaria 
63 Table (13): Comparison of haemoglobin between uncomplicated malaria and the clinical categories of the severe malaria 
64 Table (14): Plasma Amino acids levels  
65 Table (15): Comparison between the mean of amino acids in uncomplicated malaria and severe anaemia 
66 Table (16): Comparison between the mean of amino acids in uncomplicated malaria and cerebral malaria 
67 Table (17): Comparison between the mean of amino acids in uncomplicated malaria and convulsions 
68 Table (18): Comparison between the mean of amino acids in uncomplicated malaria and hypoglcaemia 
72 Table (19): Means of Hb, Insulin, C-peptide, K, and arginine in jaundice cases 
72 Table (20): Means of Hb, RBG, and insulin for fatality cases  
75 Table (21):  Expected values of insulin in severe and uncomplicated malaria  
 
 9
List of figures  
 
 
43 Fig (1): Reaction between the amino acid and ninhydrine 
43 Fig (2): Flow chart of amino acid analyzer 
47 Fig (3): Distribution of the study population according to age 
49 Fig (4): Characterization of the samples according to criteria of malaria 
51 Fig. (5): Mean of RBG in uncomplicated and severe malaria 
52 Fig. (6): Mean of insulin in severe and uncomplicated malaria 
53 Fig. (7): Prevalence of hypoinsulinaemia  in severe and uncomplicated malaria 
54 Fig. (8): Mean of C-peptide in severe and uncomplicated malaria 
57 Fig. (9): Correlation between Insulin and RBG in  Severe malaria 
57 Fig. (10): Correlation between Insulin and RBG in  uncomplicated malaria 
58 Fig. (11): Correlation between insulin and c-peptide in severe malaria in molar unit 
59 Fig. (12): Correlation between insulin and C-peptide in uncomplicated malaria in molar unit 
60 Fig. (13): Mean of K+ in severe and uncomplicated malaria 
62 Fig. (14): Mean of Hb in severe and uncomplicated malaria 
70 Fig. (15): Mean of Glucogenic plasma amino acids in severe  malaria 
71 Fig. (16): Large neutral amino acid levels in clinical categories of severe malaria 
 10
ABSTRACT 
 
Back Ground   
 
Severe and complicated Plasmodium falciparum infections continue to threaten the 
survival of young children in sub-Saharan Africa.  A reduction in the mortality and 
morbidity may only come about by better understanding of the pathophysiological 
processes that are responsible for the manifestation of severe malaria.  
 
Hypoglycemia is a frequently encountered complication in falciparum malaria that is 
usually ascribed to increased glucose uptake and impaired glucose production caused by 
the inhibition of gluconeogenesis.  
This study sets out to examine the pathophysiological aspects of severe malaria in 
children related to blood glucose homeostasis, prevalence and possible causes of 
hypoglycaemia in severe malaria. It also examines clinical indicators and laboratory 
parameters associated with severe malaria in children, so as to propose appropriate 
laboratory tests as indicators for high risk children with severe malaria. 
 
Patients and Methods 
This is a cross- sectional cohort study based on clinical presentations and laboratory 
findings. It was conducted at Khartoum Paediatric and Bashaeir Hospitals during the 
period September 2006 to September 2007. The total number of patients with malaria 
included in this study and confirmed by thin and thick blood films were 80 patients. 
Children from 0 to 12 years with Plasmodium falciparum infection were included in the 
study using the WHO inclusion criteria for severe malaria (45 children). For comparison 
a matched group of uncomplicated malaria was studied (35 children).  
All patients underwent a complete clinical examination with general and systemic 
examination by a medical doctor in hospital. Five ml of venous blood were taken from 
each patient in both groups on admission after informed consent.  All laboratory 
investigations were done on blood samples collocted before treatment. Hb, K+, Random 
blood glucose, insulin, C-peptide, urea and the serum amino acids were measured in both 
groups of patients. 
Results 
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Children with severe malaria were younger (mean age, 4.7years) compared to those with 
uncomplicated malaria (mean age, 8.1years).  
Hypoglycaemia was an uncommon complication; it was found only in two patients, 
(4.4%) of patients with severe malaria. No difference was found in random blood 
glucose levels in children with severe and uncomplicated malaria (99.58 and 96.18 
mg/dl respectively). The mean insulin level was significantly lower in patients with 
severe malaria 5.31 mIU/L, compared with the mean in the uncomplicated malaria 
group 8.59 mIU/L (P, 0.01). The mean of C-peptide was nearly equal between the two 
groups and no significant difference was found. However the incidence of 
hypoinsulinaemia in severe malaria was significantly higher (P, 0.002). 
 
Hypokalaemia was found to be common in both groups but the incidence was much 
higher in patients with uncomplicated malaria. 
                                                                                             
Arginine concentrations were low in individuals with severe malaria (25.63µmol/l) and 
uncomplicated malaria (29.79µmol/l). Arginine was significantly lower in severely 
anaemic patients (19.3 µmol/l) compared with uncomplicated malaria (29.79µmol/l). But 
it was also found that most of the amino acids were consistently lower in patients with 
anaemia. Glucogenic amino acids did not show differences between the two groups. 
Phenylalanine was significantly higher in severe malaria than uncomplicated malaria (P 
=0.001), particularly in cerebral malaria. Large neutral amino acids (except tryptophane) 
were significantly higher in patients with cerebral malaria. Children who had convulsions 
did not show any significant difference in the mean of amino acids except for 
Phenylalanine which was significantly higher; but not to the extent found in cerebral 
malaria.  
  
Conclusions: Hypoglycaemia was an uncommon complication in this study. The study 
suggests unimpaired gluconeogenesis in severe and uncomplicated malaria except for the 
two patients with hypoglycaemia. Insulin levels were significantly low in the severe 
malaria group compared with uncomplicated malaria. As C-peptide did not show a 
difference between the two groups. This study suggests a decreased half life of insulin in  
severe malaria.  Arginine concentrations were low in individuals with severe and 
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uncomplicated malaria which indicates reduced NO production and therefore reduced   
killing of patients. Large neutral amino acids and in particular phenylalanine were 
significantly higher in CNS involvement and may be part of the pathogenesis of cerebral 
malaria. 
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 ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
 ﺔﺘﻤﺜل ﺨﻁﺭﺍﹰ ﻋﻠﻰ ﺤﻴﺎﺓ ﺍﻻﻁﻔﺎل ﻓﻰ ﺍﻟﻤﻨﺎﻁﻕ ﺸﺒﻪ ﺍﻟﺼﺤﺭﺍﻭﻴ ﻪﻤﺎﺯﺍﻟﺕ ﺍﻹﺼﺎﺒﺔ ﺒﺎﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤ
ﻴﻤﻜﻥ ﺘﺨﻔﻴﺽ  ﻪﻭﻤﺭﻀﻴﺔ ﺍﻟﻤﺴﺌﻭﻟﺔ ﻋﻥ ﻅﻬﻭﺭ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺴﻴﺍﻟﻔ ﻟﻙ ﻓﺎﻥ ﺍﻟﺒﺤﺙ ﻓﻰ ﻭﻟﺫ. ﺒﺎﻓﺭﻴﻘﻴﺎ
ﻟﻠﻤﺭﺽ  ﺔﺍﻟﻌﻼﺠﻴﺨﻁﺔ ﺍﻟﻭﺍﻟﻭﻓﻴﺎﺕ ﻭﺍﻴﻀﺎﹰ ﻤﻌﺭﻓﺔ ﻨﺘﻴﺠﺔ ﺍﻹﺼﺎﺒﺔ ﺒﺎﻟﻤﺭﺽ ﻗﺒل ﺇﺒﺘﺩﺍﺀ  ﻪﻀﺍﻤﺭﻟﻨﺴﺒﺔ ﺍ
 ﻬﻼﻙﺇﻟﻰ ﺇﺯﺩﻴﺎﺩ ﺇﺴﺘ ﻯﺨﻁﻭﺭﺓ ﻭﻴﻌﺯ ﺎﻋﻔﺎﺕﺍﻨﺨﻔﺎﺽ ﻤﻌﺩل ﺍﻟﺠﻠﻜﻭﺯ ﻓﻰ ﺍﻟﺩﻡ ﻴﻌﺩ ﻤﻥ ﺃﻜﺜﺭ ﺍﻟﻤﻀ.
ﺭ ﻴﻁ ﻋﻤﻠﻴﺔ ﺍﻨﺘﺎﺝ ﺍﻟﺠﻠﻜﻭﺯ ﻤﻥ ﻤﻭﺍﺩ ﻏﺜﺒﻴﺇﻨﺘﺎﺝ ﺍﻟﺠﻠﻜﻭﺯ ﺒﺎﻟﺩﻡ ﺍﻟﻨﺎﺘﺞ ﻋﻥ ﺘﻓﻲ ﺨﻠل  ﻜﻭﺯ ﻭﺃﻴﻀﺎﹰﻠﺍﻟﺠ
  .ﻜﺎﺭﺒﻭﻫﻴﺩﺭﺍﺘﻴﺔ 
ﺃﺠﺭﻴﺕ .  ﻪﻭﺯ ﻓﻰ ﺍﻟﺩﻡ ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺯﻴﺎﺩﺓ ﻋﻤﻠﻴﺔ ﺇﻨﺘﺎﺝ ﺍﻟﺠﻠﻜ ﺔﺍﻟﺤﺩﻴﺜ ﺒﻌﺽ ﺍﻷﺒﺤﺎﺙﺃﻅﻬﺭﺕ 
ﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻟﺴﺭﻴﺭﻴﺔ ﺒﺜﺒﺎﺕ ﺍﻟﺠﻠﻜﻭﺯ ﻓﻰ ﺍﻟﺩﻡ ، ﻪﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻤﻌﺭﻓﺔ ﺍﻟﻌﻤﻠﻴﺎﺕ ﺍﻟﻔﻴﺴﻭﻟﻭﺠﻴﺔ ﺍﻟﻤﺘﻌﻠﻘ
ﻟﻠﻌﻤل  ﺇﻗﺘﺭﺍﺡ ﺇﺨﺘﺒﺎﺭﺍﺕ ﻤﻌﻤﻠﻴﺔ ﻤﻼﺌﻤﺔ ﻭﻓﻰ ﺍﻷﻁﻔﺎل  ﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪﻟﻠ ﻪﺍﻟﻤﺅﺩﻴﻭﺍﻟﻤﺨﺘﺒﺭﻴﻪ 
  .ﻪ ﺎﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺒ ﻜﻤﺅﺸﺭﺍﺕ ﺨﻁﻭﺭﺓ ﺍﻟﻤﺭﺽ ﻋﻠﻰ ﺍﻷﻁﻔﺎل ﺍﻟﻤﺼﺎﺒﻴﻥ
  :ﺍﻟﻁﺭﻕ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﻭﺍﻟﻤﺭﺽ 
ﻴﻘﻭﻡ  ﻫﺫﺍ ﺍﻟﺒﺤﺙ ﻋﻠﻰ ﺩﺭﺍﺴﺔ ﻤﻘﻁﻌﻴﺔ ﻟﻤﺠﻤﻭﻋﺔ ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﺘﻌﺘﻤﺩ ﻋﻠﻰ ﺍﻟﻔﺤﺹ ﺍﻟﺴﺭﻴﺭﻱ 
ﻡ ﺍﻟﻰ ﺴﺒﺘﻤﺒﺭ  6002ﺇﺠﺭﻴﺕ ﺍﻟﺩﺭﺍﺴﻪ ﻓﻰ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﺸﻬﺭ ﺴﺒﺘﻤﺒﺭ ﻤﻥ ﺍﻟﻌﺎﻡ . ﻭﺍﻻﺨﺘﺒﺎﺭﺍﺕ ﺍﻟﻤﻌﻤﻠﻴﻪ
ﺠﻨﻭﺏ ﻭﻗﺩ ﻜﺎﻥ ﺍﻟﻌﺩﺩ ﺍﻹﺠﻤﺎﻟﻰ  ﺒﻤﺴﺘﺸﻔﻰ ﺍﻟﺨﺭﻁﻭﻡ ﻟﻸﻁﻔﺎل ﻭﻤﺴﺘﺸﻔﻰ ﺒﺸﺎﺌﺭ ﺍﻟﺨﺭﻁﻭﻡ 8002
ﻁﻔﻼﹰ ﻤﺼﺎﺒﻴﻥ ﺒﺎﻟﻤﻼﺭﻴﺎ ﺒﻌﺩ ﺍﻟﺘﺄﻜﺩ ﺍﻟﻤﻌﻤﻠﻰ ﻟﻠﻤﺭﺽ ﻤﻥ ﺨﻼل  08ﻟﻺﻁﻔﺎل ﺍﻟﻤﺭﻀﻰ ﻓﻰ ﺍﻟﺩﺭﺍﺴﺔ 
  .ﻋﺎﻤﺎﹰ 21 –ﺸﺭﺍﺌﺢ ﺍﻟﺩﻡ ﺫﺍﺕ ﺍﻟﻨﺘﻴﺠﻪ ﺍﻹﻴﺠﺎﺒﻴﻪ ﻭﻗﺩ ﻜﺎﻨﺕ ﺃﻋﻤﺎﺭ  ﺍﻹﻁﻔﺎل ﺘﺘﺭﺍﻭﺡ ﻤﻥ ﺼﻔﺭ 
ﻤﻥ ﺍﻟﻤﻌﺎﻴﻴﺭ ﺍﻟﻤﺤﺩﺩﺓ ﺒﻭﺍﺴﻁﺔ ﺘﻡ ﺘﻀﻤﻴﻥ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪ ﺒﻨﺎﺀ ﻋﻠﻰ ﺘﻭﻓﺭ ﻭﺍﺤﺩ ﺃﻭ ﺃﻜﺜﺭ 
ﻭﺍﻴﻀﺎﹰ ﺸﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﻪ ﻤﺠﻤﻭﻋﻪ ﺃﺨﺭﻯ ﻤﻥ . ﻤﺭﻴﻀﺎﹰ 54ﻤﻨﻅﻤﺔ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻟﻤﻴﺔ ﻭﻗﺩ ﻜﺎﻥ ﻋﺩﺩﻫﻡ 
ﺘﻡ ﻓﺤﺹ ﻜل ﻤﺭﻴﺽ . ﻤﺭﻴﻀﺎﹰ  53ﺍﻻﻁﻔﺎل ﺍﻟﻤﺼﺎﺒﻴﻥ ﺒﺎﻟﻤﻼﺭﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﻪ ﻭﻗﺩ ﻜﺎﻥ ﻋﺩﺩﻫﻡ 
ﺨﺘﺒﺎﺭﺍﺕ ﺍﻟﻤﻌﻤﻠﻴﺔ ﻤل ﻤﻥ ﺍﻟﺩﻡ ﻗﺒل ﺍﻟﻤﻌﺎﻟﺠﺔ ﻭﺫﻟﻙ ﻟﻼ 5ﺒﻭﺍﺴﻁﺔ ﺍﻟﻁﺒﻴﺏ  ﺒﺎﻟﻤﺴﺘﺸﻔﻰ ، ﺜﻡ ﺍﺨﺫ 
 –ﺍﻟﺒﻭﻟﻴﻨﺎ  – editpep-C –ﺍﻹﻨﺴﻠﻴﻥ  –ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ  –ﺍﻟﺠﻠﻜﻭﺯ  –ﻗﻴﺎﺱ ﺍﻟﻬﻴﻤﻭﻏﻠﺒﻴﻥ : ﺍﻟﺘﺎﻟﻴﻪ 
  . ﺍﻻﺤﻤﺎﺽ ﺍﻷﻤﻨﻴﻪ
  :ﺍﻟﻨﺘﺎﺌﺞ 
( ﺴﻨﻪ 7.4=ﻤﺘﻭﺴﻁ ﺍﻟﻌﻤﺭ)ﺍﻟﺼﻐﻴﺭﺓ  ﺍﻷﻋﻤﺎﺭ ﺫﻭﻱ ﻜﺎﻨﻭ ﻤﻥ ﻪﺒﺎﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤ ﺍﻟﻤﺼﺎﺒﻴﻥ ﺍﻻﻁﻔﺎل
ﻭﻗﺩ .(ﺴﻨﻪ 1.8=ﻤﺘﻭﺴﻁ ﺍﻟﻌﻤﺭ) ﺍﻜﺒﺭ ﻋﻤﺭﺍﹰ ﺍﻜﺎﻨﻭ ﻴﻥﺫﻟﺍ ﺒﺎﻟﻤﻼﺭﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﻪ ﺒﺎﻟﻤﺼﺎﺒﻴﻥ ﻤﻘﺎﺭﻨﻪ
ﻭﺠﺩ ﺃﻥ ﻤﺘﻭﺴﻁ %(.4.4)ﻭﺠﺩ ﻤﺭﻴﻀﻴﻥ ﻓﻘﻁ ﻤﻥ ﺍﻟﺩﺭﺍﺴﻪ ﻴﻌﺎﻨﻭﻥ ﻤﻥ ﺇﻨﺨﻔﺎﺽ ﺍﻟﺴﻜﺭ ﻓﻰ ﺍﻟﺩﻡ 
ﺩﺴﻠﺘﺭ ، ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻐﻴﺭ ﻭﺨﻴﻤﻪ / ﻏﻡ 85.99ﻤﺴﺘﻭﻯ ﺍﻟﺠﻠﻜﻭﺯ ﻓﻰ ﺍﻟﺩﻡ ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪ 
ﻤﺘﻭﺴﻁ ﻤﺴﺘﻭﻯ ﺍﻻﻨﺴﻠﻴﻥ ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ .ﺘﻴﻥ ﺩﺴﻠﺘﺭ ﻭﻟﻡ ﻴﻭﺠﺩ ﻓﺭﻕ ﻤﻌﻨﻭﻯ ﻴﺒﻥ ﺍﻟﻤﺠﻤﻭﻋ/ ﻏﻡ  81.69
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ﻟﺘﺭ ﻭﻟﻡ ﻴﻅﻬﺭ ﺃﻱ ﻓﺭﻕ /ﻤل ﻭﺤﺩﻩ  95.8ﻟﺘﺭ ﻭﻟﻠﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺔ  /ﻤل ﻭﺤﺩﻩ  13.5ﺍﻟﻭﺨﻴﻤﻪ ﻜﺎﻥ 
ﻭﻟﻜﻥ ﻭﺠﺩ ﺇﻥ . ﻤﻌﻨﻭﻱ ، ﻜﻤﺎ ﻟﻡ ﻴﻅﻬﺭ ﻤﺘﻭﺴﻁ ﺍﻟﺴﻰ ﻴﻴﺘﻴﺩ ﻭﺠﻭﺩ ﺍﻯ ﻓﺭﻕ ﻤﻌﻨﻭﻯ ﺒﻴﻥ ﺍﻟﻤﺠﻤﻤﻭﻋﺘﻴﻥ
  . ﺤﺩﻭﺙ ﻤﻌﻨﻭﻱ ﻜﺎﻥ ﺫﻭ ﺍﻟﻭﺨﻴﻤﻪ ﻓﻰ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻱ ﺍﻻﻨﺴﻠﻴﻥ ﺤﺩﻭﺙ ﺇﻨﺨﻔﺎﺽ
ﻤﺴﺘﻭﻯ ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ ﻓﻲ ﺍﻟﺩﻡ ﻜﺎﻥ ﻤﻨﺨﻔﻀﺎﹰ ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﺤﺎﻻﺕ ﻓﻲ ﺍﻟﻤﺠﻤﻭﻋﺘﻴﻥ ﺍﻻ ﺍﻥ ﺤﺩﻭﺜﻪ ﺍﻜﺜﺭ 
  . ﻭﺫﻭ ﺇﺨﺘﻼﻑ ﻤﻌﻨﻭﻱ ﻓﻲ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺔ
ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﺔ     ) ﻤﺴﺘﻭﻯ ﺘﺭﻜﻴﺯ ﺍﻟﺤﻤﺽ ﺍﻷﻤﻴﻨﻰ ﺍﻻﺭﺠﻨﻴﻴﻥ ﻜﺎﻥ ﻤﻨﺨﻔﺽ ﺒﻜﻠﺘﺎ ﺍﻟﻤﺠﻤﻭﻋﺘﻴﻥ 
ﻭﺠﺩ ﺍﻥ ﺍﻟﺤﻤﺽ ﺍﻻﻤﻴﻨﻰ ( ﻟﺘﺭ / ﻤﺎﻴﻜﺭﻤﻭل 97.92ﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﺔ ﻟﺘﺭ ﻭﺍﻟﻤﻼﺭ/ ﻤﺎﻴﻜﺭﻤﻭل 36.52
. ﺍﻻﺭﺠﻨﻴﻴﻥ ﻜﺎﻥ ﺫﻭ ﺍﻨﺨﻔﺎﺽ ﻤﻌﻨﻭﻯ ﻓﻰ ﻤﺭﻀﻰ ﻓﻘﺭ ﺍﻟﺩﻡ ﺍﻟﺤﺎﺩ ﻤﻘﺎﺭﻨﻪ ﺒﺎﻟﻤﻼﺭﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﻪ
ﺍﻟﻔﻨﻴﻨﻴل ﺍﻷﻨﻴﻥ ﻜﺎﻥ . ﻤﻌﻅﻡ ﺍﻻﺤﻤﺎﺽ ﺍﻻﻤﻨﻴﺔ ﻜﺎﻨﺕ ﺫﺍﺕ ﺍﻨﺨﻔﺎﺽ ﺒﺜﺒﺎﺕ ﻓﻰ ﻤﺭﻀﻰ ﻓﻘﺭ ﺍﻟﺩﻡ ﺍﻟﺤﺎﺩ 
. ﻤﻘﺎﺭﻨﺔ ﺒﺎﻟﻤﻼﺭﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﻪ ﺨﺎﺼﻪ ﻓﻰ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ ﺫﻭ ﺍﺭﺘﻔﺎﻉ ﻤﻌﻨﻭﻯ ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ
ﺍﻷﺤﻤﺎﺽ ﺍﻻﻤﻴﻨﻴﺔ ﺍﻟﻜﺒﻴﺭﺓ ﺍﻟﻤﺤﺎﻴﺩﺓ ﻤﺎﻋﺩﺍ ﺍﻟﺘﺭﺒﺘﻭﻓﺎﻥ ﺍﻴﻀﺎﹰ ﻜﺎﻨﺕ ﺫﻭ ﺍﺭﺘﻔﺎﻉ ﻤﻌﻨﻭﻯ  ﻓﻰ ﻤﺭﻀﻰ 
  .ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ 
  :ﺍﻟﺨﻼﺼﺔ 
ﻟﻰ ﻋﺩﻡ  ﺃﺜﺒﺘﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻥ ﺇﻨﺨﻔﺎﺽ ﻤﻌﺩل ﺍﻟﺴﻜﺭ ﻓﻲ ﺍﻟﺩﻡ ﻻ ﻴﺤﺩﺙ ﺍﻻ ﻨﺎﺩﺭﺍﹰ ﻭﺫﻟﻙ ﻴﻌﺯﻯ ﺇ
ﻏﻴﺭ  ﻓﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪ ﻭ ﻪﺭ ﻜﺎﺭﺒﻭﻫﻴﺩﺭﺍﺘﻴﻴﻌﻤﻠﻴﺔ ﺇﻨﺘﺎﺝ ﺍﻟﺠﻠﻜﻭﺯ ﻤﻥ ﻤﻭﺍﺩ ﻏﺤﺩﻭﺙ ﺨﻠل ﺒ
ﻓﻲ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪ ﻤﻘﺎﺭﻨﺔﹰ   ﻤﻌﻨﻭﻴﺎﹰ ﻜﺎﻥ ﻤﻨﺨﻔﻀﺂ ﺍﻨﺨﻔﺎﺽ ﻤﺴﺘﻭﻯ ﺍﻻﻨﺴﻠﻴﻥ .ﺍﻟﻭﺨﻴﻤﺔ
ﻟﻰ ﺍﻨﺨﻔﺎﻀﺎﹰ ﻤﻤﺎﺜﻼﹰ ﻓﻘﺩ ﻋﺯﻯ ﺫﻟﻙ ﺍ  ﻭﺤﻴﺙ ﺍﻨﻪ ﻟﻡ ﻴﻅﻬﺭ ﺍﻟﺴﻰ ﻴﻴﺘﻴﺩ. ﺒﺎﻟﻤﻼﺭﻴﺎ ﻏﻴﺭ ﺍﻟﻭﺨﻴﻤﻪ
ﺸﺎﺌﻌﺂ  ﺍﻨﺨﻔﺎﺽ ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ ﻜﺎﻥ. ﺍﻨﺨﻔﺎﺽ ﺍﻟﻌﻤﺭ ﺍﻟﻨﺼﻔﻲ ﻟﻼﻨﺴﻠﻴﻥ ﻓﻲ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻭﺨﻴﻤﻪ
  .ﺒﻜﻠﺘﺎ ﺍﻟﻤﺠﻤﻭﻋﺘﻴﻥ ﻓﻰ ﺍﻟﺩﺭﺍﺴﻪ
ﺍﻟﺤﻤﺽ ﺍﻻﻤﻴﻨﻲ ﺍﻻﺭﺠﻨﻴﻴﻥ ﻜﺎﻥ ﻤﻨﺨﻔﻀﺎﹰ ﻓﻲ ﻜﻼ ﺍﻟﻤﺠﻭﻋﺘﻴﻥ ﻭﻴﻤﻜﻥ ﺍﻥ ﻴﺅﺩﻱ ﺫﻟﻙ ﺍﻟﻰ ﺍﻨﺨﻔﺎﺽ 
ﺍﻟﻤﺘﻌﺎﺩﻟﺔ ﺨﺎﺼﺔ ﺍﻟﻔﻴﻨﻴل ﺍﻷﻨﻴﻥ ﺍﻨﺘﺎﺝ ﺍﻭل ﺍﻜﺴﻴﺩ ﺍﻟﻨﻴﺘﺭﻭﺠﻴﻥ ﻜﻤﺎ ﺍﻥ ﺍﻻﺤﻤﺎﺽ ﺍﻻﻤﻴﻨﻴﺔ ﺍﻟﻜﺒﻴﺭﺓ 
  . ﺍﻅﻬﺭﺕ ﺍﺭﺘﻔﺎﻋﺎﹰ ﻤﻌﻨﻭﻴﺎﹰ ﻓﻲ ﻤﺭﻀﻰ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ
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INTRODUCTION 
 
Malaria accounts for one in five of all childhood deaths in Africa. Each year, 
approximately 300 to 500 million malaria infections lead to over one million deaths of 
which over 90% occur in African children. The situation is complicated by the increasing 
occurrence of Plasmodium falciparum parasite resistant to chloroquine and other 
antimalarial drugs.1, 2, 3 In regions holo- or hyperendemic for malaria, the greatest 
suffering is children less than five years of age. It is less common in older children and 
adults, because of the acquisition of partial immunity,4 whereas in areas of low 
endemicity with special reference to central Sudan, the disease affects all age groups.5 
Early diagnosis and appropriate treatment are essential to reduce morbidity and mortality 
related to malaria.6,7 Prompt and appropriate classification and treatment of malaria helps 
identify the most severely ill children and aids early and appropriate management of the 
severely ill child. 8, 9 
Changes in management of severe forms of malaria over the last 40 years have not had a 
significant impact on survival. A reduction in the mortality and morbidity may only come 
about by better understanding of the pathophysiological processes that are responsible for 
severe malaria that determine the outcome even before antimalarials medication has had 
time to work.10 Clinical studies in Africa suggest that the pathophysiology of severe 
malaria is different in children and adults. Identifying the underlying pathophysiological 
mechanisms may help to improve survival.11  
Recognizing at risk patients through chemical pathological tests and clinical signs is seen 
as a measure for improving the outcome of chemotherapy. This study aims at derstanding 
the underlying pathophysiology which contributes to severe malaria and fatal outcomes. 
 
Epidemiological Profile 
The epidemiological profile and clinical pattern of severe malaria in African has been 
shown to be modulated by the intensity of exposure and pattern of transmission. 12 
The expert malaria committee of WHO has classified the degree of malaria endemicity 
according to the spleen rates: 
• Hypoendemic malaria: It is defined as malaria in areas where the spleen rates <10% in 
children 2-9 years.  
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• Mesoendemic malaria: It is defined as malaria in areas where the spleen rates 11-50% 
in children 2-9 years. 
• Hyperendemic malaria: It is in the areas where the spleen rates are constantly over 50% 
in children 2-9 years.  
• Holoendemic area: It is in the areas where the spleen rates in children 2-9 years 
constantly over 75%, with low spleen rates in adults. It is in this type of endemicity, 
that the strongest adult tolerance is found. 
• Stable malaria (Holo& hyperendemic): It occurs where transmission rates are 
continuously high throughout the year, and do have seasonal fluctuation in morbidity 
and mortality patterns. 
• Unstable malaria (meso & hypoendemic): It occurs where there is seasonal endemicity, 
with one or two annual transmission.13 
 
Malaria in Sudan 
Malaria is the leading cause of morbidity and mortality in Sudan, with an annual 
estimated 7.5 million clinical cases and 35,000 deaths.14, 15 Malaria in Sudan is the main 
endemic parasitic disease. The endemicity varies accordingly to the natural distribution of 
the geographical zones, being hypoendemic in the north, mesoendemic to hypoendemic 
in the central areas and hyprendemic in the tropical areas in the south.14  
 
Plasmodium falciparum is the prevalent parasite throughout the country; it is responsible 
for 90% of infections16, 14 and the main mosquito vector is Anopheles Arabiensis, An. 
gambiae and An. Funestus.14 Plasmodium vivax is widespread in the eastern part of the 
country, while in the south of Sudan the other species are found P. vivax, P.malaria and 
P.ovale.16 
Factors that determine the development of mild versus severe malaria are not fully 
understood.  It has become apparent that death from severe malaria may arise from a 
wide spectrum of pathophysiological changes. Many pathophysiological aspects of severe 
malaria are still not completely understood.  
 
Recently various studies have started to shed light on the pathophysiological changes that 
may lead to high risk in severe malaria. This study investigates the pathophysiology of 
 17
hypoglycaemia in severe malaria in children. The focal points of the research are on 
blood glucose homeostasis. However, recent studies have pointed to the metabolism of 
amino acids playing a role not only in glucose homeostasis but also in other aspects of the 
pathogenesis of severe malaria. 
 
Cerebral malaria is associated with decreased production of nitric oxide and decreased 
levels of its precursor, L-arginine.17, 18 Lopansri in 2006 have found that phenylalanine 
homeostasis is disrupted in severe malaria, leading to significant 
hyperphenylalaninemia.17 Abnormal amino acid metabolism may thus be an important 
factor in the pathogenesis of the clinical manifestations. Studies of changes in the free 
amino acids plasma pool in malaria are limited.  We sought to determine if other amino 
acid abnormalities are associated with disease severity in falciparum malaria. Fatal 
outcomes in severe malaria may be due to hypoglycaemia, renal dysfunctions, circulatory 
failure or a combination of them.  
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CHAPTER ONE 
LITREATURE REVIEW 
Life Cycle of the Malaria Parasite 
Human infection is initiated when sporozoites are injected with the salvia during 
mosquito feeding. Besides mosquito bites, malaria can also be transmitted via blood 
transfusions or contaminated needles. The sporozoites enter the circulatory system and 
within 30-60 minutes will invade a liver cell. After invading the hepatocyte; the parasite 
undergoes an asexual replication. This replicative stage is often called exoerythrocytic (or 
pre-erythrocytic) schizogony. Schizogony refers to a replicative process in which the 
parasite undergoes multiple rounds of nuclear division without cytoplasmic division 
followed by a budding, or segmentation, to form progeny. The progeny, called 
merozoites, are released into the circulatory system following rupture of the host 
hepatocyte.   
In comparison with other malaria parasites, P. falciparum has a shorter pre-erythrocytic 
stage (5–7 days), prepatent period (interval between infection and the appearance of 
parasites in the erythrocytes), and incubation period (interval between infection and onset 
of symptoms). It also produces more merozoites from liver schizonts and after 
erythrocytic merogony.10, 19 In P. vivax and P. ovale some of the sporozoites do not 
immediately undergo asexual replication, but enter a dormant phase known as the 
hypnozoite. This hypnozoite can reactivate and undergo schizogony at a later time 
resulting in a relapse.20  
Merozoites released from the infected liver cells invade erythrocytes. After entering the 
erythrocyte the parasite undergoes a trophic period followed by an asexual replication. 
The young trophozoite is often called a ring form due to its morphology in Geimsa-
stained blood smears. Rings synthesize protease to degrade haemoglobin into amino 
acids. These and other nutrients obtained from the host enable the parasite to grow in 15-
18 hours to mature torophozites. The torophozites then undergo schizogony and to yield 
about 16 merozoites that are released by the rupture of the RBC to continue the asexual 
blood stage cycle.  An asexual RBC cycle takes 48 hours in P. falciparum and P.vivax, 
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some invading haploid merozoites develop into male and female gametocyte within the 
RBC. Gametocytes undergo gametogenesisin in the mosquito midgut following 
ingestion.  Sporozites produced in the oocyst then migrate to the salivary gland of the 
mosquito to continue the infection cycle.20 
Antimalarial Drugs 
Africa carries the greatest burden of disease caused by Plasmodium falciparum, and it is 
expect this burden to rise in the near future, mainly because of drug resistance.3 
Resistance of P. falciparum to most Antimalarial drugs currently in use has been 
documented in almost all countries where there is transmission.1 Chloroquine has been in 
use for treatment of malaria in Sudan for more than 40 years.  Recent treatment protocols 
have given up chloroquine, because of the high level chloroquine resistance (75%). 
Quinine is the standard treatment for severe or complicated malaria.  
 Artemisinin combination therapy may offer considerable advantages over alternative 
therapies. Use of the artemisinin (ART) group of drugs (artesunate, artemether, 
dihydroartemisinin, artemisinin and arteether) reduces the parasite biomass very quickly, 
also on the basis of extensive human use, seem to be safe.3 However, with the shift to 
artemisinin-based combination therapy (ACTs) in Sudan, the issue of treatment-seeking 
was considered as the cost of drugs is clearly higher compared to the cost of 
chloroquine.15 
 Clinical Picture of Malaria  
Clinical symptoms and signs of malaria occur when P. falciparum-infected erythrocytes 
multiply asexually. The hepatic stages and gametocytes are asymptomatic.10 For a child 
living in an endemic area the illness is quite different depending on the age and the 
degree of immunity. In areas of high malaria transmission, severe malaria mainly affects 
children under five years of age. In other areas, all age groups are at risk of developing 
severe malaria, although the reported mortality varies considerably depending upon the 
age, immunity, clinical complications and access to appropriate treatment.4 The clinical 
manifestations of malaria are extremely diverse and may range in severity from mild 
headache to the development of pulmonary oedema. 
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The incubation period: It is time between the infection and appearance of the clinical 
symptoms. It varies with difference species of malaria. In Plasmodium Falciparum it is 
from 9-14 days. The highest temperature occurs around the time of schizogony of 
asexual. 
The cold stage: It lasts 1-2 hours. When the patient feels chilliness, shaking, shivering 
and he piles on the bed clothes. 
The hot stage: It lasts 3-4 hours. When the patient’s temperature is high (up to 40-41 C), 
his skin is dry and he throws off the bedclothes. 
The sweating stage: it lasts 2-4 hours, when the patient and his bed clothes are soaked in 
sweat and the temperature falls rapidly and exhausted.16  
Clark suggested alternative toxins were responsible for the clinical features of severe 
malaria, initially suggesting endotoxins.21 The fever, febrile paroxysms, a variety of 
aches and pains and prostration, the most familiar and consistent symptoms of an acute 
malaria attack are probably the result of schizont rupture, hemozin and other toxic factors 
such as phosphate isomers stimulate macrophages and other cells to produce cytokines 
and other soluble factors. 22 
Uncomplicated Malaria 
The presentation of uncomplicated P. falciparum malaria is very variable and mimics that 
of many other diseases. Although fever is common, it is absent in some cases. The fever 
is initially persistent rather than tertian. The expectation that P. falciparum malaria 
should have a tertian fever pattern may lead to the diagnosis of malaria being missed with 
a consequent delay in treatment. The fever may or may not be accompanied by rigors. 
True rigors are relatively unusual in acute falciparum malaria.2 The patient commonly 
complains of fever, headache, and aches and pains elsewhere in the body, and 
occasionally of abdominal pain and diarrhoea. In a young child there may be irritability, 
refusal to eat and vomiting. On physical examination fever may be the only sign. In some 
patients the liver and spleen are palpable. This clinical presentation in non-endemic or 
low-endemic areas may be misdiagnosed as influenza. Unless the condition is diagnosed 
and treated promptly the clinical picture may deteriorate at an alarming rate and often 
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with catastrophic consequences. Recognizing and promptly treating uncomplicated P. 
falciparum malaria is therefore of vital importance.2  
 
Severe Falciparum Malaria 
Severe malaria is caused by Plasmodium falciparum infection and usually occurs 
predominantly in patients with little or no background immunity, and also as a result of 
delay in treating an uncomplicated attack of falciparum malaria.2, 4 Plasmodium 
falciparum is the most common cause of severe and life-threatening malaria.4  In Africa, 
a vast majority of these deaths occur in children under five years of age4,9 and pregnant 
women as a result of immature and weakened immunity respectively.23 The 
manifestations of severe malaria differ depending on the age of the patient, previous 
exposure and geographical distribution.9,10,24  
  Severe malaria was defined according to the World Health Organisation,25  on the basis 
of the presence of one or more of the following features in addition to asexual forms of P. 
falciparum in the patient’s blood: 
• Cerebral malaria (defined as unrousable coma). 
• Severe normocytic anaemia with haemoglobin less than 5 g/dl or with hematocrit < 
15%.  
• Renal failure - urine output less than 400 ml in 24 hours in adults failing to improve 
after rehydration and a serum creatinine of more than 260 µmol/l. 
• Pulmonary oedema or acute respiratory distress syndrome (ARDS). 
• Hypoglycaemia—a whole blood glucose concentration of less than 2.2 mmol/l. 
• Circulatory collapse or shock (systolic blood pressure < 50 mm Hg in children 1-5 
years old; < 70 mm Hg in adults) 
• Spontaneous bleeding from gums, nose, gastrointestinal tract, other sites and/or 
substantial laboratory evidence of disseminated intravascular coagulation (DIC). 
• Repeated generalized convulsions. More than two generalized seizures in 24 hours 
despite cooling 
• Acidaemia—an arterial pH less than 7.25 or it defined as a plasma bicarbonate 
concentration less than 15 mmol/l. 
• Macroscopic haemoglobinuria.  
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Other manifestations of severe malaria mentioned by WHO but do not themselves define 
severe malaria, include the following: 
• Impairment of consciousness less marked than unrousable coma. 
• Prostration or weakness so that the patient is unable to sit or walk. 
• Hyperparasitaemia (>5% in non-immune patients). 
• Jaundice—a serum bilirubin concentration greater than 50 µmol/l. 
• Hyperpyrexia—a rectal temperature of greater than 40°C.      
 Studies of Severe Malaria in African Children 
Newton and et al in 1998 studied the pathophysiology of fatal falciparum malaria in 
African children. They found that three overlapping clinical syndromes, metabolic 
manifesting as hyperpnea, cerebral malaria, and severe anemia, are responsible for nearly 
all the deaths in African children.11 
Study on the clinical presentation of severe malaria in Sudanese children (144 patients) in 
2002, the age for children patients was a risk factor for the severity of the disease while 
the gender was not. Severe anaemia was the most common presenting complication of 
severe malaria, it was recorded in (45.8 %) patients followed by cerebral malaria 
(22.9%), generalized repeated convulsions was (13.2%), hypoglycaemia (5.6%), acute 
renal failure (1.4%) and  respiratory distress  only (0.7%) impaired level of consciousness 
was (10.4%), Hyperparasitaemia (4.9%) and jaundice (4.9%). There was no correlation 
between the level of parasitaemia and outcome. 16   
In Gabonese children with severe falciparum malaria, 8 most children presenting with 
severe falciparum malaria were less than 5 years. Anaemia was the most frequent feature 
of severe malaria, followed by respiratory distress, cerebral malaria, hyperlactataemia 
and then hypoglycaemia. Anaemia was more common in children under 18 months old, 
while cerebral malaria usually occurred in those over 18 months. The prognostic 
indicators with the highest case fatality rates were coma/seizures, hyperlactataemia and 
hypoglycaemia, and the highest case fatality rate was in children with all three of these 
features. 8 
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A hospital-based study of severe P. falciparum in El Gadarif town 2004.26 Severe malaria 
was recognized in all age groups, but most of patients were aged 2 to 4 years. The 
predominant complication was severe anemia followed by convulsions, cerebral malaria 
and hypotension.  
Pathophysiology of Severe Malaria 
The pathology and clinical manifestations associated with malaria are almost exclusively 
due to the asexual erythrocytic stage parasites. Blood stage schizogony in P. falciparum 
differs from the other human malarial parasites in that trophozoite- and schizont-infected 
erythrocytes adhere to capillary endothelial cells and are not found in the peripheral 
circulation. 4, 27  
There are two major theories to explain the pathogenesis of human cerebral malaria 
(CM). The ‘mechanical obstruction’ hypothesis suggests that CM is a consequence of the 
adherence of PRBCs to the cerebral microvascular endothelium, leading to vascular 
obstruction and cerebral hypoxia28 and systemic effects of the excessive release of the 
cytokines that regulate cell-mediated immunity, and in particular TNF, may play an 
important role in causing some of the pathological changes that characterized malaria.29, 
30  Plasma concentrations of the cytokine tumor necrosis factor-alpha (TNF-α) are 
elevated in children with severe P. Falciparum infections, particularly those with fatal 
infections.31, 32, 33 TNF-α produced in response to schizont rupture may exacerbate 
parasite sequestration by stimulating the endothelium to express parasite-binding 
receptors such as intracellular adhesion molecule-1 (ICAM-1) and CD-36. 34 The 
administration of monoclonal anti-TNF, reduced temperature, indicating bioactivity 
against pyrogenic cytokines, but did not affect outcome and mortality. 35, 36  
Sequestration of Parasitized Red Blood Cells 
Sequestration is thought to be a specific interaction between parasitized red blood cells 
(PRBCs) and the vascular endothelium (cytoadherence).37 The sequestration of red blood 
cells containing  mature forms of the parasite (torophozites and schizont) in the 
microvasculature is thought to cause the major complications of falciparum malaria, 
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particularly cerebral malaria and prognosis is related to sequestered biomass.10, 24, 38- 40 
This process varies considerably between organs (the brain is particularly affected) and at 
a micovascular level varies between vessels.41  
Plasmodium falciparum malaria infected erythrocytes sequesters in the microcirculation 
of vital organs, interfering with microcirculatory flow and host tissues metabolism. The 
metabolically active sequestered parasites may compete with host tissues for substrates 
for instance, glucose, amino acids, nucleosides and also produce toxins that interfere with  
host tissue metabolism.41, 42   
 
 The adhesion of the PRBCs reduces the microvascular blood flow, which may explain 
organ and tissue dysfunction such as coma.24   The sequestration of PRBCs in relatively 
hypoxic venous beds allows optimal parasite growth and removes most of them from the 
circulation, thereby preventing their destruction by the spleen.41 The peripheral blood 
parasite count is a relatively poor predictor of the size of this biomass.43  There is no 
association between the density of the peripheral parasitaemia and the density of 
sequestered PRBCs.44, 45   
 
Cytoadherence occurs predominately in capillaries and venules, as it is overcome by large 
shear stresses encountered on the arterial side. 24 It is mediated by parasite derived protein 
called P. falciparum erythrocyte membrane protein -1(PfEMP-1), which is protruding 
from PRBCs surfaces.46- 50 These proteins have adhesive properties and are primarily 
responsible for cytoadherence. This family of large proteins (200-350 kDa) expressed on 
the exterior of PRBCs vary antigenically with time in cloned parasites. PfEMP-1 is 
encoded by the highly variable VAR gene, which comprising more than 150 genes. The 
high switch rate between these genes gives rise to a new variant PfEMP-1. There by 
allows the parasites to evade host immune responses.24, 51   
 
On the vascular endothelium numerous receptors that can bind PFEMP-1 have been 
identified, with different distributions in various organs. Main candidate CD36 seems to 
be expressed at all times in wide range of vascular beds but remarkably absent in brain 
vessels, and are regarded as constitutive; their expression is not related qualitatively or 
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quantitatively to severity of disease.52, 53  The intracellular adhesion molecule-1 (ICAM-
1) is the most important receptor on brain endothelium, which is expressed in the cerebral 
vessels of patients with cerebral malaria.53, 54 ICAM-1 co-localizes with sequestration, 
suggesting that they may be responsible for cytoadherence.Other receptor such as 
endothelial selectin (E-selectin), which are also expressed in cerebral vessels.10, 24    
In addition the deformability of both parasitized and uninfected erythrocytes is markedly 
reduced in severe malaria, and this is strongly associated with fatal outcome of the 
disease.55, 56   Acting synergistically with the reduction in lumen caused by sequestration, 
rigid erythrocytes reduce blood flow in the microcirculation of vital organs, causing 
dysoxya with lactic acidosis, organ dysfunction and death. In addition formation of 
erythrocyte clumps through resetting and agglutination could further compromise flow.53  
Features of Severe Malaria in Children 
In children, the complications of severe malaria include severe anaemia, which is a 
common presenting feature in the first two years of life. In older children seizures and 
cerebral malaria predominate. In adult acute renal failure, acute pulmonary oedema, liver 
dysfunction, and cerebral malaria may all occur. Metabolic acidosis, mainly lactic 
acidosis, is common at all stages.9, 24, 57     
Cerebral Malaria 
 
Cerebral malaria (CM) is one of the most common causes of child death in sub-Saharan 
Africa. It is a diffuse encephalopathy in which focal neurological signs are relatively 
unusual.24 African children with cerebral malaria are older, than children with other 
complications of the disease.26, 58 The direct cause of coma in cerebral malaria remains 
obscure.4,53Acompromised microcirculation, with sequestration of parasitized 
erythrocytes, is central in the pathogenesis of CM.53, 59  
Central nervous system (C.N.S) dysfunction in falciparum malaria could be due multiple 
factors. To differentiate various causes of transient cerebral dysfunction, a strict 
definition of cerebral malaria has been developed for a diagnosis of cerebral malaria,60 
the following criteria should be met:  Deep, unarousable coma, Motor response to 
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noxious stimuli is non-localizing or absent (unable to localize pain or a Blantyre Coma 
score_<2) with an asexual parasitemia of a P. falciparum. Coma should persist at least 30 
minutes after a generalized convulsion to exclude transient post-ictal coma. Exclusion of 
other encephalopathies, Hypoglycemia, meningoencephalitis, eclampsia, intoxications, 
head injuries, cerebrovascular accidents and metabolic disorders should be excluded as 
the cause of coma.4, 24, 58, 61, 62 Immunological reactions such as immune complex 
vasculitis and various cytokines such as tumor necrosis factor-alpha (TNF- α) were 
involved in cerebral malaria.63  
 
Cerebral malaria is a major complication in severe cases, especially when associated with 
hypoglycaemia and anemia. Cerebral malaria presents usually with a 1-4 day history of 
fever and convulsions.62  Focal motor and generalised tonic-clonic convulsions are the 
most common clinically detected seizures.24, 50, 53   
 
 Seizures are important presenting features of CM, being witnessed in more than 50% of 
African children with CM.53, 62, 64 Seizures, particularly those witnessed after admission 
in children with CM, are associated with death.61, 62  Hypoglycaemia can occur in about 
20% of children with cerebral malaria at the time of admission to the hospital. 
Restoration of normoglycaemia, however is often not associated with a change in the 
level of consciousness.11, 24   
 
The median time for recovery of consciousness in children is approximately 32.2 hours.4, 
24 Most deaths in children admitted to hospital with CM occur within first 24 hours of 
starting treatment.4, 58, 62, 64 Some investigatiors have concluded that symptoms of 
cerebral malaria are due to stagnant hypoxia caused by adherence of (PRBCs) to 
endothelium of cerebral venules and capillaries.53  
 
 In the neurological examination, the eyes often show a divergent gaze. Pupil and corneal 
reflexes are usually normal (corneal reflexes may be lost in deep coma). There may be 
passive resistance to neck flexion, but of a lesser degree than in meningities.24, 53 Retinal 
hemorrhage can be observed in about 15% of cases.64 
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Patients can present with hypertonic posturing (decorticate& decerebrate pattern). 
Abdominal and corneal reflexes are absent.11, 61, 64  An abnormal plantar reflex is seen in 
many cases. Ankle and patellar clonus can sometimes be elicited in hypertonic patients.24 
Bruxism is common in cases with deep coma.4, 24, 53  African children with cerebral 
malaria show an unexplained increase in blood brain barrier permeability with disruption 
of endothelial intracellular tight junctions on autopsy.66, 67   
 
Increased intracranial pressure (ICP) is associated with poor outcome in pediatric 
encephalopathies.11, 68  Monitoring ICP confirmed that children deeply unconscious from 
cerebral malaria had raised ICP, and those children who developed severe intracranial 
hypertension either died or survived with severe neurological sequelae. It can cause death 
by transtentorial herniation or a reduction in cerebral perfusion pressure.11, 24, 69   Opening 
CSF pressures are increased in most African children with cerebral malaria.11, 24, 70-72     
Transient brain swelling may occurred in children with intermediate intracranial 
hypertension and tomographic features of cytotoxic oedema were seen in children who 
developed severe intracranial hypertension.11 The most likely cause of increased ICP in 
Cm is an increased in intracranial blood volume as a consequence of sequestration of 
PRBCs in the vascular compartment, either acting as a diffuse space occupying lesion or 
obstructing venous outflow. Also increased cerebral blood flow could be caused by other 
features of CM, such as seizures, hyperthermia, and anaemia.24, 70  
 
A study on the relationship between the presenting feature and outcome in 131 Malawian 
children admitted with cerebral malaria showed that, the presenting clinical signs were 
significantly associated with adverse outcome (death or sequale) were profound coma 
(15%), signs of decerebrating, absence of corneal reflexes, convulsions at the time of 
admission and age under three years. Laboratory findings hyperparasitaemia, elevated 
plasma concentration of alanine and 5-Nuclotidaseand elevated plasma or cerebrospinal 
fluid lactate were of prognostic significance. Children having four or more of these 
prognostic indicators had an eight fold higher risk of adverse outcome than those with 
fewer than four. 62  
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Neurological sequelae:  
The causes of the sequelae are largely unknown and are likely to be multifactorial. In 
children neurological residual abnormalities are more common and they often die with 
features of brain death.10 Neurological sequelae are rare in adults recovering from CM.4, 
53 About 10% of children who survive cerebral malaria have neurological sequelae2, 62, 73    
which persist into the convalescent period. Sequelae may take the form of cerebellar 
ataxia, hemiparesis, speech disorders, cortical blindness, behavioural disturbances, 
hypotonia or generalized spasticity.2, 4, 53 Neurological sequelae are associated with 
protracted seizures, prolonged and deep coma, hypoglycaemia,and severe anaemia in 
some studies. Severe neurological sequelae are associated with severe intracranial 
hypertension.24, 69    
 
Seizure 
Seizures are the other common neurological manifestation of falciparum malaria, often 
precipitating admission to hospital.4 Convulsions are an important complication of 
malaria in young children, and are associated specifically with P. falciparum infection, 
even in otherwise uncomplicated malaria.74 Compared with adults, children have a higher 
incidence of seizure. P. falciparum seems to be particularly epileptogenic. Although fever 
may precipitate some seizures, most seizures occur when the rectal temperatures are less 
than 38.0oC. 
 By comparison with simple febrile seizures, the seizures in malaria are often recurrent, 
and 84% of the seizures are complex, with 47% being partial and over 70% repetitive.75 
The seizures may be caused by intracranial sequestration of metabolically active parasites 
or "toxins" produced by the parasites, but seem not to be associated with hypoglycaemia 
and hyponatraemia.62  
 
Severe Anaemia 
Aneamia is an inevitable consequence of malaria infection especially in children, 
pregnant and lactating women. Severe anaemia can be one of the life-threatening 
complications of P. falciparum infections, although in African children, it is associated 
with a relatively low mortality on its own, but much higher when associated with CM or 
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acidosis.58 The mechanisms of anaemia are multi factorial and complex, involving 
haemolysis and an inappropriate bone marrow.4  
 
  The main causes of anaemia are destruction of parasitized and non- parasitized 
erythrocytes50, as all parasitized cells (PRBCs) are destroyed at schizogony, the survival 
of non- parasitized erythrocytes (NPRBCs) was found to be reduced for several weeks 
after clearance of parasitaemia in patients; an exoerythrocytic mechanism such as 
increased removal by the spleen seems to be responsible.13, 16 Malnutrition and changes 
in immune response patterns due to prolonged exposure to P. falciparum may contribute 
to the development of this complication.76  
 
 The rate of development and degree of anaemia depend on the severity and duration of 
parasitaemia. In some children, repeated untreated episodes of otherwise uncomplicated 
malaria may lead to normochromic anaemia in which dyserythropoietic changes in the 
bone marrow are prominent. Children with hyperparasitaemia may develop severe 
anaemia rapidly. In these cases, acute destruction of parasitized red cells is responsible.2 
There is initial iron sequestration with low serum iron level, but massive 
hyperferritinaemia.4  
 
Furthermore, NO is involved in the pathogenesis of malarial anaemia by suppressing 
haematopoiesis and inducing erythrocyte destruction.77 Also decreased in plasma 
glutamine in acute falciparum malaria may increase susceptibility to dyserythropoiesis.4 
Spleen often becomes dark from malarial pigment, enlarged, soft and friable. There is 
reticular hyperplasia. Recurrent malaria is associated with hard, fibrous splenic 
enlargement. 50  
 
Hypotension/shock 
 
Systolic BP < 50 mmHg in children and < 80 mmHg in adults defines hypotension/shock. 
Patient with severe malaria can develop sudden hypotension and become shocked. This is 
called “Algid Malaria”. The patient can have cold, clammy, cyanotic skin, peripheral 
vasoconstriction, and rapid feeble pulse with core/skin temperature difference of ≥ 10. 
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Algid malaria is sometimes associated with bacterial infection of blood (septicaemia).16, 
50 Circulatory collapse can also be seen in patients with pulmonary, oedema, metabolic 
acidosis, GI haemorrhage, and ruptured spleen. Dehydration and hypovolaemia could 
also contribute to hypotension/ shock.2, 50 
  
Fever 
It is defined as rectal temperature > 40° C (104° F) in adults and children. High fever (39-
40° C) is especially common in children and may contribute to convulsion and altered 
consciousness.4 Fever is non-specific reaction of the body to infection, functioning at 
least in part to increase the rate of metabolic reactions. It is important in host defenses. 
Fever in malaria is correlated with maturation of a generation of merozites and the 
rupture of the red cells that contain them. It is widely believed that fever is stimulated by 
the waste products of the parasite, which relased them with the erythrocytes lyse. The 
release of these malarial antigens into the circulation apparently tiggers aburst of (TNF) 
from activated macrophages.16  
 
The role of fever in the pathophysiology of severe malaria is undetermined. Fever may 
synchronise the stages of parasites,10 promoting the survival of parasites. In Gambian 
children with uncomplicated malaria, the increased resting energy expenditure is 37% 
higher compared with when they have recovered, and this is associated with a doubling 
of whole body protein turnover assessed by stable isotope techniques.79 Elevations in 
body temperature are important in increasing energy expenditure (by between 8.5 and 
13.2%/°C), but are not the only mechanism causing these rises. The rise in temperature 
during malaria infections is thought to be mediated by TNF, which is an endogenous 
pyrogen, acting on the hypothalamus to reset the set-point for temperature homeostasis.36 
Although the fact that not all fevers are associated with elevations in TNF suggests that 
other mechanisms may also be involved.10  
 
Hyperparasitaemia 
It is defined as a parasitaemia of > 5% (> 250,000 parasites/microl) in peripheral blood 
smear in nonimmune individuals.2 A parasitaemia of > 10% indicates potentially 
dangerous infection, irrespective of other factors. But in endemic areas, partially immune 
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children can tolerate high degree of parasitaemia up to 20% - 30% without clinical 
symptoms.50  
 
Jaundice 
The liver plays a key role in the life cycle of the malarial parasite and in some cases it is 
seriously affected. Hyperbilirubinaemia is attributable to intravascular haemolysis of 
parasitized erythrocyte, disseminated intravascular coagulation and hepatic dysfunction. 
In endemic areas, jaundice is seen in approximately 2.5% of patients with falciparum 
malaria.80 Although hemolytic jaundice is not uncommon in malaria, massive 
intravascular hemolysis has been recognized as the pathogenic mechanism of jaundice in 
falciparum malaria. Unconjugated bilirubin is often elevated and may be associated with 
evidence of intravascular hemolysis in the form of hemoglobinemia and hemoglobinuria. 
However, malarial hepatopathy with rise in Conjugated bilirubin is not uncommon. 
Enzyme elevation, however, is only mild. 81 Although the primary schizogony of the 
malarial parasite always leads to the rupture of the infected hepatocyte, alteration of the 
hepatic functions is uncommonly recorded due to this event. 80  
 
 Renal Failure 
Acute renal failure and pulmonary oedema are common complications of falciparum 
malaria and a major cause of death in adults,82- 84  but are rarely seen in African 
children58- 61 Elevation in plasma creatinine, however is common in childhood CM10   
and although it is associated with death, 61 none of the children die from renal failure. A 
disproportionate increase in urea suggests that the elevated creatinine is probably caused 
by hypovolaemia85 and aggressive intravascular volume repletion may be required in 
some children. 86 Renal impairment can also be caused by a glomerulonephritis from the 
circulating immune complexes, intravascular haemolysis manifesting as blackwater fever. 
The glomerulonephritis is seen in nonimmune patients,10 but rarely documented in 
African children.  
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Electrolyte Abnormalities  
Hyponatraemia (Na+ <135 mmol/L) occurs in over half of the patients with severe 
malaria, particularly CM.4, 85 The cause of the hyponatraemia is controversial. English 
and colleagues argued that hyponatraemia results from an appropriate hormonal response 
to the loss of electrolyte and fluid in sweat and stool. Yet, the children with most severe 
hyponatraemia were less dehydrated (lower urea and less weight gain after treatment).it 
also attributed to inappropriate secretion of antidiuretic hormone.87  
Hyponatremia is observed in the majority of adult and pediatric patients with severe 
malaria.85 A number of underlying mechanisms have been proposed, including the 
administration of hypotonic fluids, the syndrome of inappropriate anti-diuretic hormone 
secretion (SIADH).88 Hyponatremia in adults with severe malaria is common and 
associated with preserved consciousness and decreased mortality. It likely reflects 
continued oral hypotonic fluid intake in the setting of hypovolemia and requires no 
therapy beyond rehydration.89  
 
Hypokalaemia (K+ <3.5 mmol/L) was present in 14% on the day of admission in 
survivors, but this may increased to 39% the following day. There was speculation that 
hypokalaemia may contribute to a variety of complications, such as cardiac dysrhythmias 
and late respiratory arrest. However, dysrhythmias are not important complications of 
malaria in children. Hyperkalaemia is uncommon in severe childhood malaria, and if it 
occurs, it is often associated with severe haemolysis or renal impairment.10  
Metabolic Acidosis 
Metabolic acidosis (pH< 7.30) is due to the accumulation of any acid other than carbonic 
acid and there is primary decrease in the plasma bicarbonate. The commonest metabolic 
complications (lactic acidosis and hypoglycaemia) arise from increased host anaerobic 
metabolism probably due to a mismatch between tissue oxygen supply and requirement. 
90 Metabolic acidosis may be the sole indicator of a complicated falciparum infection, in 
which case the predominant clinical symptoms are respiratory (deep breathing, 
intercostal/subcostal recession).91  
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Various manifestations of systematic metabolic acidosis have been described in children 
with P. falciparum infections. Acidemia in Malwian children,91 hyperlactatemia in 
Gambian children,61, 92 and hyperpnea in Kenyan children,93 are all strongly associated 
with disease severity. Hypovolaemia in sick children with severe malaria is a commonest 
cause of acidosis.9, 94,  95   
There are several potential causes of hyperlactataemia of malaria, Sequestration of 
parasitized red blood cells in brain and muscle is found in severe malaria, Lactate: 
pyruvate ratios in severe malaria are extremely high ( 30). There is a positive correlation 
between lactate turnover and blood lactate concentrations, implying that increased 
production not decreased clearance.95 Several factors which increase lactate production, 
are present in malaria including fever, severe anaemia, hypovolaemia, altered rheological 
properties of non-parasitized red blood cells (NPRBC), recent seizure activity, the 
products of parasite metabolism and decreased elimination through impaired hepatic 
blood flow and function.11, 96, 97 However, hyperlactataemia is not the only cause of 
acidosis in malaria. Ketoacidosis is a common finding in children with severe malaria in 
Kenya and Papua New Guinea.97  
 
Acidosis and hypoglycaemia are strongly associated11 suggesting that parasite and  host 
metabolism may contribute to the derangements. P. falciparum derives most of its energy 
from anaerobic glycolysis, and the latter stages (late trophozoites and meronts) are the 
most metabolically active, which are sequestered in various tissues. The sequestration 
may compromise local blood flow and enhance local glucose consumption, force the 
tissues into anaerobic metabolic state, which lead to increased lactic acid production.84, 98  
Altered respiratory rates and rhythmus are commonly observed in acidotic pediatric 
malaria patients. Kussmaul respiration are a compensatory response to metabolic acidosis 
to achieve a state of compensated metabolic acidosis, therefore, the vast majority of cases 
of malaria with respiratory distress are accompanied by metabolic acidosis.11, 94  
Pulmonary oedema is a fatal complication of severe Falciparum malaria. 2, 4  
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Hypoglycaemia 
Disturbances in glucose metabolism, especially Hypoglycaemia, complicate severe 
malaria in both adult and paediatric patients, it is more common in children than adult 
and it may be difficult to detect clinically. Hypoglycemia is a serious complication 
especially when associated with cerebral malaria, owing to its consequences of brain 
damage and neurological sequelae and, in children with severe malaria, its association 
with high death rates, amounting to 33 and 36.8% in studies in Gambian and Malawin, 
respectively.31, 33, 99, 100 In Kenyan children with severe malaria the mortality in 
hypoglycaemic children was 20.2% compared to 3.8% in normoglycaemic children.103 In 
African children, hypoglycaemia is an important and treatable manifestation of severe 
malaria and is unrelated to antimalarial treatment.99, 100   
 
Pretreatment hypoglycaemia is more common in children.4, 99, 104 Children with severe 
malaria, those having a definite episode of hypoglycaemia at some stage are more 
acidotic and have greater evidence of renal impairment than those who are never 
hypoglycaemic (mean base excess -14.4 vs. -7.2, p < 0.001, mean creatinine 97 vs. 64, p 
< 0.001 and mean urea 8.1 vs. 5.8.104 In conscious patients, hypoglycaemia may present 
in classical symptoms of breathlessness, tachycardiac, headache. More severe signs 
include generalized convulsions, deteriorating consciousness and coma.58 (58 Marsh, 
1995). Patients with severe malaria should be monitored frequently for hypoglycaemia 
and treated rapidly with intravenous glucose if hypoglycaemia is detected. 
 
In Malawian and Gambian children hypoglycaemia was associated with low plasma 
insulin concentrations and with elevated plasma concentrations of lactate, alanine, and 5'-
nucleotidase a finding that suggests that impaired hepatic gluconeogenesis but not 
hyperinsulinaemia contributes to the pathogenesis of pretreatment hypoglycemia.99, 100, 
104 In Thai adult patients with falciparum malaria, Plasma insulin concentrations were 
inappropriately high (range 1.0-21.8 mU/I), lactic acidosis was common (arterial blood 
lactic acid concentration 1.44-17.8 mM/I), but the glucose counterregulatory response, 
indicated by plasma cortisol, growth hormone, catecholamines and glucagon 
concentrations, was intact.105 The causes of hypoglycemia in African children with 
severe malaria are incompletely understood. But it has been suggested to be due to: 
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Quinine induced hypoglycaemia: 
Quinine-induced hypoglycemia is probably mediated by insulin. Quinine stimulates 
insulin release in vivo in both healthy humans and individuals affected with malaria. This 
insulin release occurs mainly in adults, especially in pregnant women and it is less 
frequent in children.4, 100, 106 Quinine was found to be a particular cause of 
hypoglycaemia after the first day of treatment of severe malaria and in pregnancy. 100  
 
Plasma insulin and C-peptide levels are frequently inappropriately high during episodes 
of hypoglycaemia, quinine and insulin concentrations are positively correlated, implying 
that hypoglycaemia in adults is due to quinine-induced hyperinsulinaemia.10, 102   
However, Hyperinsulinemia does not seem to occur in children.99, 100 Hypoglycaemia 
with appropriately low insulin levels has been observed in African children with severe 
malaria. Hypoglycaemia was not finding it to be a complication of quinine treatment in 
children. 99  
 
Non-insulin-related hypoglycaemia: 
Hypoglycaemia can also occur in adults and children with severe malaria who do not 
receive quinine. Studies have shown that such individuals have plasma insulin 
concentrations that are equivalent during fasting or are even below the detection level of 
the assay. Thus, these individuals show appropriate insulin response to hypoglycaemia, 
indicating that hypoglycaemia in untreated malaria is not due to hyperinsulinemia. In 
light of recent data showing that glucose production and gluconeogenesis are often 
increased in falciparum malaria, because plasma glucose concentration is the result of 
glucose production and glucose consumption, the etiological causes can be divided into 
two groups: (i) those related to increased consumption of glucose; and (ii) those related to 
decreased production of glucose.107  
Increased glucose consumption: 
Increased glucose turnover in acute Falciparum malaria was attributed to increase 
glucose consumption by host and parasite.4, 10 Glucose turnover is correlated positively 
with lactate turnover, suggesting that glucose is mainly consumed by anaerobic 
glycolysis.108  Elevated glucose turnover in severe malaria results mainly from anaerobic 
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glycolysis, which in turn results from decreased oxygen delivery to tissues because of 
microvascular obstruction. Skeletal muscle responds to falling hepatic pyruvate 
concentrations by augmenting alanine release109 which is then deaminated to pyruvate 
and converted subsequently to glucose in the glucose–alanine cycle. 
Although parasitized red cells use more glucose than unparasitized cells there is no 
relationship between circulating parasitaemia and blood glucose turnover or 
concentration, and the amount of parasitized red cells is not sufficient to cause the 
observed hypoglycaemia.4 Therefore Parasite consumption is considered to be a 
‘contributing factor’ rather than the ‘causative factor’ of hypoglycaemia because of the 
big difference in glucose demand between the parasites and the severely ill, febrile 
patient.107  In the host, the high metabolic demands of the febrile illness will increase the 
glucose need.110 It has been shown that the glucose clearance rate increases by 40–70% 
in severe malaria, but by only 20% in uncomplicated falciparum malaria.107, 111   
Decreased glucose production: 
• Glycogen depletion:  In children, fasting reduces glycogen stores rapidly, even in well 
nourished; therefore, postmortem examination often fails to detect hepatic glycogen. 
Thus, the particular susceptibility to hypoglycaemia of children with severe 
falciparum malaria is frequently, at least in part, ascribed to limited glycogen stores.4 
This association has been supported by a study of Thai adults with malaria, which 
found that the plasma glucose response to intravenous glucagon, a test for glycogen 
stores, is often diminished. 102  
• Impaired gluconeogenesis: Failure of, or impaired, hepatic gluconeogenesis is 
considered to be an important causative factor of hypoglycemia in malaria.4, 99, 102   
Observed increases in the plasma concentration of some gluconeogenic precursors 
(lactate and alanine) are consistent with an inhibition of gluconeogenesis.62, 102, 104   
The increase in glucose turnover and impaired conversion of alanine and pyruvate to 
glucose all point to a pivotal role of anaerobic glycolysis in the pathogenesis of 
hypoglycaemia in severe malaria.  However, the pathogenic mechanisms responsible 
for such impairment are incompletely understood.102 Recent data have shown instead 
of a decrease in glucose production, there is an increase in glucose production in all 
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patient groups for both uncomplicated and complicated disease due to a rise in 
gluconeogenesis. 111, 113, 114  
Fasting as a risk factor in hypoglycaemia in severe malaria: 
In malaria, the rate of glycogen breakdown after an overnight fast is considerably lower 
than in healthy subjects. If glycogen content regulates its rate of breakdown during 
fasting, we postulate that the rate of glycogenolysis should decrease faster in patients 
with malaria than in healthy subjects.115  
Studies of hypoglycemia in severely ill children including a group of children with severe 
malaria, have demonstrated a relationship between fasting, hypoglycemia, severity of 
disease and mortality.103, 107 Also Studies of hypoglycaemia in malaria have not strongly 
considered or emphasized fasting as an important risk factor. Malaria, a disease that 
induces anorexia, can have a prolonged course. Epidemiological studies on hypoglycemia 
in malaria do not usually correct for duration of starvation as an independent variable.107 
In healthy humans starvation of 86 hours is known to result in low plasma glucose levels 
(3.5 mmol/l) owing to a decrease in glucose production.116 In uncomplicated malaria, 
individuals can avail themselves of food without help, but in severe malaria – and 
cerebral malaria in particular – the supply of glucose and food is dependent on attendants 
and medical staff.107  
In individuals with cerebral malaria, glucose production after an overnight fast is 
completely derived from gluconeogenesis and declines in the next 24 h at the same rate 
as in healthy subjects (Thien, 2004 C50) cerebral malaria therefore seems to shorten the 
length of time for which a patient can tolerate fasting. 
The combination of anorexia and starvation (active or passive) can lead to, and/or be the 
underlying cause of, hypoglycemia, thereby explaining the high prevalence of 
hypoglycemia in severe malaria in pregnancy. The high frequency of hypoglycemia in 
children with malaria is also understandable because of the dependence of children on 
attendants for food in addition to their high glucose requirements and low glycogen stores 
in comparison to adults. 107  
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Amino Acids Changes in Malaria 
Amino acids play many important roles in living systems. They are used as building 
blocks for peptides which in turn serve to provide structure, transport or catalysis in the 
organisms. Circulating amino acids serve primarily as substrates for protein synthesis, 
metabolic energy (oxidation through the carboxylic acid cycle), or gluconeogenesis, 
ketogenesis.  
Human can synthesize 12 of the 20 common amino acids from amphibolic of glycolysis 
and of the citric acid cycle. Of the 12 nutritionally nonessential amino acids, nine are 
formed from amphibolic intermediates and three and three (Cysteine, tyrosine, and 
hydroxylysine) from nutritionally amino acids. Essential amino acids cannot be 
synthesized in sufficient amounts by the body and therefore must be obtained from the 
diet in order for normal protein synthesis to occur. Amino acids whose catabolism yields 
pyruvate or one of the intermediates of the citric acid cycle are termed glucogenic amino 
acids. Transamination or deaminations of glucogenic amino acids yield either pyruvate or 
intermediates of the citric acid cycle.  Amino acids serve as chemical, transmitters and 
precursors of neurotransmitter in the central nervous system:  
Excitatory neurotransmitter amino acids 
• Glutamate is the main excitatory transmitter in the brain and spinal cord. It is the 
transmitter responsible for 75% of the excitatory transmitter in the brain. 
Glutamate is formed by reductive transamination of intermediate α- Ketoglutrate 
in the Krebs cycle.  
• Aspartate is apparently a transmitter in pyramidal cells and spiny stellate in the 
visual cortex. Aspartate is formed by transamination of the Krebs cycle 
intermediate oxaloacetate. 
Inhibitory neurotransmitter amino acids  
• Gamma- amino butyric acid (GABA) is the major inhibitory mediator in the 
brain, where it is the transmitter at 20% of CNS synapses. It is formed by 
decarboxylation of glutamate.  
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• Glycine is responsible in part for direct inhibition, primarily in the brain stem and 
spinal cord act as inhibitory neurotransmitter. The clinical picture of convulsions 
and muscular hyperactivity produced by strychnine emphasize the importance of 
postsynaptic inhibition in normal neural function.                                                                            
The optimum amino acid balance in the body is an essential and often critical component 
of mental health state. Altered amino acid metabolism in response to malaria infection 
may contribute to disease severity. 
 
Arginine 
The amino acid arginine plays a key role in many metabolic processes in health and 
disease, such as detoxification of ammonia (urea cycle), synthesis of polyamines and 
creatine, modulation of immune function, and synthesis of nitric oxide (NO). It is 
transported from blood into cells by cationic amino acid transporter (CAT) isoforms.  
Arginine is synthesized from citrulline by successive actions of argininosuccinate 
synthetase (AS) and argininosuccinate lyase (AL), the third and fourth enzymes of the 
urea cycle (ornithine cycle). Arginine generated in the urea cycle is rapidly converted to 
urea and ornithine by arginase with no net synthesis of arginine. Another major site is the 
kidney, where arginine is synthesized from citrulline and is released into the blood. 
Citrulline is also formed from arginine as a co product of NOS reaction, can be recycled 
to arginine by AS and AL in the citrulline-NO cycle. AS and AL are expressed strongly 
in the liver and kidney and at very low levels in many other tissues and cells. 
 
Arginase, an enzyme that converts L-arginine to ornithine and urea, can limit NO 
bioavailability through increased consumption of the substrate for NO synthase. Arginase 
exists in two isoforms, liver-type arginase I and nonhepatic-type arginase II. Arginase 
found predominantly in the liver and kidneys. It is also present in human red blood cells, 
and it can be induced in many cell types by a variety of cytokines and inflammatory 
stimuli. Furthermore, since arginine and ornithine compete for the same transport system 
for cellular uptake, a decrease in the arginine-to-ornithine ratio resulting from increased 
arginase activity could further limit arginine bioavailability for NO synthesis.117 Thus, 
arginase and NOS use arginine as a common substrate and may compete with each other 
for this substrate.118  
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Arginine is considered a conditionally essential amino acid because endogenous arginine 
synthesis may not be sufficient to meet metabolic needs, especially during growth 
(infants and children) 119 and during highly catabolic conditions such as sepsis and burns. 
Children with critical illness may therefore be at particular risk of developing arginine 
deficiency.120 
 
Low plasma arginine concentrations have been described in children with various 
pathological conditions, such as in premature infants with necrotizing enterocolitis (NEC) 
121 and children with asthma,122 cerebral malaria,17 or sickle cell crisis.123 
Hypoargininaemia was significantly associated with cerebral malaria case-fatality. It may 
contribute to limit NO production in children. Whether or not some of the severe of the 
sequelae are caused by, or results from, hypoargininaemia is unclear. 17, 18 
  
Role of NO in malaria 
These endothelial cells (EC) express a variety of biological activities, including the 
control of vascular tone and blood flow through the secretion of vasoactive substances. 
Many different stimuli act on the endothelial cells to produce endothelium-derived 
relaxing factor (EDRF), which is now known to be nitric oxide (NO). Nitric oxide is 
synthesized from the amino acid L-arginine by a family of enzymes, the nitric oxide 
synthases (NOS).124 The nitric oxide synthase in immune cells (NOS 2) is not induced by 
Ca2 as in NOS 1 and NOS 3 but is activated by cytokines.  The availability of arginine is 
one of the rate-limiting factors in cellular NO production.124, 125 The NO that is formed in 
the endothelium diffuses to smooth muscle cells, where it causes relaxation of vascular 
smooth muscles. This can explain a protective role by diminishing sequestration of 
PRBCs. 
 
The vascular endothelium plays a central role in the pathogenesis of severe malaria. 
Parasitized red cells adhere to constitutive and cytokine-inducible receptors on the 
microvascular endothelium, resulting in sequestration and vascular obstruction, impaired 
perfusion, and tissue dysoxia in critical organs.126, 127 
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Among a number of vasoactive factors that play pivotal roles in regulating vascular 
reactivity are endothelin (ET)-1 and nitric oxide (NO). ET-1 is a member of the 
endothelin family, composed of two other isopeptides (ET-2 and ET-3). Impairment in 
NO production and/or increased release of ET-1 are key initiators of endothelial 
dysfunction and injury. Endothelin, a potent vasoconstrictor peptide can affect vascular 
tone and blood pressure in human and may be involved in such pathological states as 
atherosclerosis, pulmonary hypertension, congestive heart failure, renal failure , and 
blood-brain barrier function. 
 
Nitric oxide (NO) forms part of the immune response but at the same time contributes to 
the pathogenesis of infectious diseases. 128 NO is a messenger molecule functioning in 
vascular regulation, host immunity, defense, neurotransmission, and other systems. 
Diseases such as vascular dysfunction are associated with impaired production of NO, 
whereas septic shock, cerebral infarction, diabetes mellitus, and neurodegenerative 
disorders are associated with NO overproduction.129  
 
Immune responses involve the interactions of multiple cell types, including lymphocyte, 
monocyte, other inflammatory cells, and endothelium. P. falciparum-infected 
erythrocytes produce pyrogenic material that triggers the release of TNF (and other 
cytokines) from host mononuclear cells.130 As TNF is known to induce nitric oxide (NO) 
this molecule has been proposed to act as a contributor to malaria associated 
pathology.131, 132  
 
 The potential roles for NO in malaria and other parasitic diseases are many, and have 
effects both protective and harmful to the host.128 It has been argued, for instance, that 
excess NO, generated in critical locations by iNOS, could be functionally important in 
falciparum malaria, accounting for some of the reversible cerebral symptoms131, 133 and 
malarial tolerance.134 There is evidence for its involvement in the immunosuppression 
and weight loss seen in experimental malaria.135  
 
More recently the researchers believe that nitric oxide has a protective effect against 
malaria rather than pathological role in African children.136- 139 NO has antiparasitic 
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effects in vitro and probably protects against disease by decreasing amounts of 
proinflammatory cytokines, reducing expression of endothelial cell surface adhesion 
molecules, and preventing parasite cytoadherence.124, 140   
 
Glutamine 
Glutamine is the most abundant circulating amino acid in the human body and is involved 
in more metabolic processes. Glutamine is used for hepatic urea synthesis, renal ammonia 
genesis, gluconeogenesis and nucleotide biosynthesis. Glutamine can be synthesized by 
most tissues from α-ketoglutrate and glutamate via aminotransferase and glutamine 
synthetase. Glutamine is not classed as an essential amino acid, but becomes 
conditionally essential in catabolic states.  
Plasma glutamine levels are low in patients with critical illness141, 142  post trauma143 in 
burns patients144 and in pre-term infants145 which can be improved by glutamine 
supplementation. Cowan and et al in 1999146 conclude that acute falciparum malaria is 
associated with large decreases in plasma glutamine and these falls may increase 
susceptibility to sepsis and dyserythropoesis.146  
 
 Planche and et al in 2002147 have found that plasma glutamine levels are low in 
uncomplicated and moderate malaria infection. In contrast, plasma glutamine was within 
the normal range in those with severe malaria. Moreover, children with severe malaria 
who subsequently died had significantly higher plasma glutamine levels than those who 
survived.  There are several possible explanations for this finding: There may be 
increased glutamine release into plasma in severe malaria, plasma clearance of glutamine 
may be decreased, the volume of distribution of glutamine may have decreased, or a 
combination of mechanisms may operate. Glutamine is an excitatory transmitter in many 
parts of the brain includes the basal ganglia and the cerebral cortex, and may therefore 
explain CNS involvement in severe malaria.147  
 
Phenylalanine 
Phenylalanine is an essential amino acid that cannot be synthesized by humans. The 
conversion of L- tyrosine involves irreversible oxidation by cytosolic phenylalanine 
hydroxylase. Hydroxylation of phenylalanine represents the initial step in the oxidative 
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degradation of phenylalanine and biosynthesis of tyrosine. Phenylalanine metabolism 
plays a significant role in determing the plasma concentration of tyrosine, and that the 
hydroxylation of phenylalanine is sensitive to dietary phenylalanine intake.148 
  
The causes and sequelae of chronic hyperphenylalaninemia have been well characterized 
in children with inborn errors of phenylalanine metabolism. However, less is known 
about the physiologic consequences of acute perturbations in phenylalanine metabolism, 
especially in infectious diseases.17  
 
Maintenance of plasma phenylalanine homeostasis is disrupted in severe malaria, leading 
to significant hyperphenylalaninemia. Malaria elicited significantly elevated plasma of 
phenylalanine, particularly in comatose patients. The pathological consequences of 
hyperphenylalaninemia are mainly in the brain, and may include such features as 
spasticity, and seizures.149 Hyperphenylalaninemia reduces the brain uptake of other 
neutral amino acids by inhibition of neutral amino acid transport across the human blood-
brain barrier (BBB).149, 150  
 
 In chronic kidney failure, there is impairment in the conversion of phenylalanine to 
tyrosine. As a result, tyrosine and the tyrosine/phenylalanine ratio are reduced in plasma 
and many tissues, and phenylalanine concentrations tend to be normal or slightly 
increased. Although animal studies indicate that the kidney is not a major contributor to 
the conversion of phenylalanine to tyrosine, human studies conducted in the 
postabsorptive state suggest that the kidney plays a major role in the uptake of 
phenylalanine and its hydroxylation and release as tyrosine.151  
 
Large Neutral Amino Acids (LNAA) 
Large neutral amino acids {Valine (Val), methionine (Met), isoleucine (Ile), leucine 
(Leu), phenylalanine (Phe), tryptophan (Trp), tyrosine (Tyr)} circulating in blood plasma 
are precursors for the synthesis in brain of the monoamines (Catecholamine, serotonin, 
and histamine). As well as other putative neurotransmitters such as carnosine, and 
important cofactors such as S-adenosyl-methionine152 and alterations in their 
concentrations or turnover in the brain could affect monoaminergic functions.153  
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Plasmodium falciparum infection is considered one of the commonest causes of acute 
encephalopathies in children, and disorders of monoamine metabolism in the brain may 
underlie the pathogenesis of metabolic encephalopathies.154- 155   
  
Various neurotransmitters (monoamines, amino acids, peptides) and their receptors are 
implicated in initiation and termination of seizures. Depletion of the catecholamines and 
5- hydroxytryptamine, or blocked of their receptors elicits an increase in seizure 
susceptibility, while an increase in their concentrations and turnover leads to decrease. 
Therefore altered brain levels of the relevant precursor amino acids, could explain aspects 
of the cerebral components of severe faciparum malaria in the human.156 Severe 
falciparum malaria distorts plasma levels of large neutral amino acids (NAA) and 
consequently brain uptake of individual NAA.149, 156 Enwonwu et al in 2000156 
suggested enhanced cerebral synthesis of histamine with impaired production of 
serotonin and the catecholamines in malaria patients.   
 
Aminergic System in the Brain 
There are four large aminergic systems in the brain. These are serotonergic, 
noradrenergic, adrenergic, and histaminergic systems. 
 
The Reticular Formation  
The reticular formation occupies the midventral portion of the medulla and midbrain. It 
contains the cell bodies and fibres of many of the sertonoergic, noradrenergic, and 
adrenergic systems.  It also contains many of the areas concerned with regulation of heart 
rate, blood pressure, and respiration. Some of the descending fibers in it inhibit 
transmission in sensory pathways in the spinal cord. Pathways from the pontine and 
medullary reticular formation and therefore are concerned with adjustment of the stretch 
reflex muscle tone and other reflexes. 
 
Biosynthesis and Release of Catecholamines  
The principal catecholamines found in the body are norepinepherine, epinephrine and 
dopamine. They are formed by hydroxylation and decaboxylation of the amino acid 
tyrosine. Some of the tyrosine is formed from phenylalanine, but most is of dietary 
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origin.  Phenylalanine hydroxylase is found primarily in the liver. Tyrosine is transported 
into brain and adenal modularly catecholamine- secreting neurons. It is converted to dopa 
and then to dopamine in the cytoplasm of the cells by tyrosine hydroxylase and dopa 
decarboxylase. The dopamine then enters the granulated vesicles, within which it is 
converted to norepinepherine by dopamine β- hydroxylase and then to epinephrine by 
phenylethanolamine-N- methyltransferase. 
 
 Norepinephrine:  
The cell bodies of the norepinephrine- containing neurons in the brain are located in the 
locus ceruleus and other nuclei in the pons and medulla. The normal function of the locus 
ceruleus system remains a mystery, although its electrical activity is increased by 
unexpected sensory stimuli and it may be related to behavioral vigilance. The ventral 
tegmental noradrenergic system is involved in regulation of the secretion of vasopressin 
and oxytocin, and it adjusts the secretion of the hypophysiotropic hormones that regulate 
the secretion of anterior pituitary hormones. Norepinephrine and serotonin both appear to 
be involved in the control of body temperature. 
 
Epinephrine: 
There is a system of phenylethanolamine- N- methyltransferase (PNMT) - containing 
neurons with cell bodies in the medulla that project to the hypothalamus. Those neurons 
secrete epinephrine, but their function is uncertain. Epinephrine secreting neurons also 
project to the thalamus, periaqueductal gray and spinal cord. There are appreciable 
quantities of tyramine in the central nervous system (CNS), but no function has been 
assigned to this agent. 
 
Dopamine: 
There are many dopaminergic systems in the brain. It is convenient to divide them into 
ultrashort intermediate and long system on the basis of the length of their axons. 
Intermediate- length dopamine cells include the tuberoinfundibular system, which secrete 
the dopamine into the portal hypophysial vessels that inhibits prolactin secretion. The 
incertohypothalamic system, which links the hypothalamus and the lateral septal nuclei, 
and the medullary periventricular group of neurons scattered along the walls of the third 
and fourth ventricles. The nigrostriate system, which projects from the substantia nigra to 
the corpus striatum, is involved in the motor control, and the mesocortial system, which 
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projects from the midbrain tegmentum to the limbic and frontal cortex and the olfactory 
tubercle. 
 
Histamine: 
Histamine is formed by decarboxylation of the amino acid histidine. Histaminergic 
neurons have their cell bodies in the tuberomamillary nucleus in the ventral portion of the 
posterior hypothalamus. The axons of these neurons project to all pats of the brain. There 
is evidence linking brain histamine to arousal, sexual behaviour, blood pressure, drinking, 
pain thresholds, and regulation of the secretion of several anterior pituitary hormones. 
 Serotonin: 
Serotonin (5-hydroxytryptamine, 5-HT) is present in high concentration in blood platelets 
and in the gastrointestinal tract. Lesser amounts are found in the brain. Serotonin is 
formed by decarboxylation of the amino acid tryptophan. Serotonin containing neurons 
have their cell bodies in the midline raphe nuclei of the brain stem and project to portions 
of the hypothalamus, the limbic system, the neocortex, the cerebellum, and the spinal 
cord. 
 
Glucose Homeostasis 
The Maintenance of stable levels of glucose in the blood is one of the most finely 
regulated of all homeostatic mechanisms involving the liver, extrahepatic tissues, and 
several hormones. It is essential for normal physiology in the body, particularly for the 
central nervous system. Glucose is produced mainly by the liver and in smaller but 
substantial quantities by the kidney. The liver produces glucose by glycogenolysis and 
gluconeogenesis and the kidney by gluconeogenesis because it does not store glycogen. 
Glucose production during prolonged starvation depends on hepatic and renal 
gluconeogenesis.  In the postabsoropative state, the concentration of blood glucose in 
most mammals is maintained between 4.5 and 5.5 mmol/l (80- 100 mg/dl). After the 
ingestion of a carbohydrate meal, it may rise to 5.6- 7.2mmol/l (100- 130 mg/dl) and in 
starvations, it may fall to 3.3- 3.9 mmol/l (60- 70 mg/dl).157  
 
In maintaining glucose homeostasis, the liver and kidney are dependent on the interaction 
of different regulatory mechanisms, such as the classical glucoregulatory hormones, 
glucose it self, and gluconeogenic substrate supply.157  In the last decades it has become 
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clear that paracrine mediators and the autonomic nervous system also exert a potent 
regulatory role.158  Glucagon enhances gluconeogenesis from amino acids and lactate.157 
Glucose enters cells by facilitated diffusion or, in the intestine and kidneys by secondary 
active transport with Na. In muscle, fat and some other tissues, insulin facilitates glucose 
enter into cells by increasing the number of glucose transporters in the cell   membrane.  
 
Factors Affecting Hepatic Glucose Production 
Substrate: 
The gluconeogenic substrates are lactate, glycerol, and the glucogenic amino acids 
Conversion of glucogenic amino acids, of which alanine makes the largest 
contribution.157 It accounts for 6% to 12% of total glucose production in the 
postabsoropative state.116  
 Lactate: 
Lactate formed by glycolysis in skeletal muscles and erythrocytes, is transported to the 
liver and kidney where it reforms glucose known as the lactic acid cycle. 
 
Glycerol: 
Triacylglycerol continuously undergoing hydrolysis to form glycerol which converts to 
glucose by glconeogenic mechanism in the liver and kidney. 
 
 Glucogenic amino acids: 
Glucogenic amino acids all amino acids that can be converted to any intermediate of the 
citric acid cycle or to pyruvate can be utilized for gluconeogenesis. Such amino acids are 
'glucogenic' amino acids: glycine, serine, threonine, valine ,histidine , arginine, cysteine, 
proline, alanine, glutamate, glutamine, aspartate, asparagine, methionine. Alanine and 
glutamine are the most important glucogenic amino acids.159  
 
Alanine: 
The glucose-alanine cycle transports glucose from liver to muscle with formation of 
pyruvate followed by transamination to alanine, then transport alanine to the liver, 
followed by gluconeogenesis back to glucose. Measurement of alanine clearance 
following intravenous infusion has been used previously to investigate alanine 
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metabolism in vivo.160  Pukrittayakamee et al112  in 2002, their data indicate that alanine 
clearance is impaired in acute falciparum malaria in proportion to the severity of illness 
and suggest an important role for anaerobic glycolysis in the pathogenesis of 
hypoglycaemia. 
Glutamine: 
Glutamine is predominantly a renal gluconeogenic substrate, whereas alanine 
gluconeogenesis is essentially confined to liver. Renal gluconeogenesis contributes 20-
25% to whole body glucose production (Stumvoll, 1999).    
Glucoregulatory Hormones 
The classical hormones inhibit hepatic glucose production and the counterregulatory 
hormones glucagon, epinephrine, norepinephrine, glucocorticoids, and growth hormone. 
Beside their specific effects, all glucostimulatory hormones act by increasing cytosolic 
free calcium levels. Increasing calcium levels is sufficient by itself to stimulate 
gluconeogenesis.157   
 
Insulin: 
Insulin is the main hormone concerned with regulation of carbohydrate metabolism. In 
particular insulin controls the level of blood glucose, glucose storage and utilization. 
Insulin suppresses gluconeogenesis and hepatic glucose release. It is polypeptide 
consisting of 51 amino acids. Human insulin has a molecular weight of about 
5800daltons.  The initial pre- hormone proinsulin has a molecular weight of about 11,500 
but it is then cleaved in the endoplasmic reticulum to form a proinsulin with a molecular 
weight of about 9000. Most of this is further cleaved in the Golgi apparatus to form 
insulin and C chain or connecting peptide (C-peptide). The C-peptide has no known 
function, but its blood levels indicate insulin secretion, because it is formed in equimolar 
quantities to insulin.   
 
The half life of insulin is about 5 minutes. The insulin molecule then enters the cells by 
pinocytosis and is broken down by a proteolytic enzyme. Insulin is found in plasma at a 
basal level (after an overnight fast) of about 4-16 µU/ml. Insulin secretion follows very 
closely the changes in the blood glucose level. Its rate of secretion is markedly increased 
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after food intake. Not only carbohydrate intake but also protein intake stimulates the 
release of insulin.  Entry of glucose into the B cells does not depend on insulin. B cells 
have glucose transporters in the cell membrane which do not require insulin for 
activation. An increase in intracellular Ca+2, which is responsible for releasing insulin.  
 
Insulin receptors: 
Insulin receptors are found on many types of cells in the body, including cells in which 
insulin does not increase glucose uptake. The receptor, which has a molecular weight of 
approximately 340,000, is a tetramer made up of two α and β glycoprotein subunit. When 
insulin binds to its receptors, they aggregate in patches and are taken into the cell by 
receptor- mediated endocytosis. The insulin –receptor complex enter lysosomes, where 
the receptor is broken down or recycled. The half- life of the insulin receptor is about 7 
hours. 
 
Insulin causes potassium to enter cells, with resultant lowering of the extracellular K+ 
concentration. Infusions of insulin and glucose significantly lower the K+ level in normal 
individuals and are very effective for the temperorary relief of hyperkalemia in patients 
with renal failure. Diabetic acidosis and hyperglycaemia are associated with loss of K in 
the urine with apparently normal levels of serum K. However, on insulin therapy these 
patients may rapidly develop hypokalaemia. 
 
 Insulin secretion 
Increased blood glucose: 
Immediately after a high carbohydrate meal, the glucose that is absorbed into the blood 
causes rapid secretion of insulin. Insulin in turn causes rapid uptake, storage, and use of 
glucose by almost all tissues of the body. Insulin promotes glycogenesis in the liver, 
conversion of excess glucose into fatty acids and inhibits gluconeogenesis in the liver. 
 
Cationic amino acids: 
In addition to the stimulation of insulin secretion by excess blood glucose, some of the 
amino acids have a similar effect. The most potent of these are arginine and lysine. 
Amino acids differ from glucose stimulation of insulin secretion. If administered 
intravenously in the absence of a rise in blood glucose they cause only a small increase in 
insulin. However, when administered when the blood glucose concentration is elevated, 
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the glucose- induced insulin may be as much as doubled. Thus, the amino acids strongly 
potentiate the glucose stimulus for insulin secretion. 
 
Insulin secretion caused by L-arginine-derived nitrogen oxides  
 
A number of studies have demonstrated that L-arginine triggers insulin release in the 
presence of D-glucose.161, 162 of the amino acids influencing insulin secretion, arginine 
has been the most frequently studied. Both arginine and glucose stimulate insulin 
secretion from the pancreatic ß-cells.163 
  
The underlying mechanisms are not fully elucidated. The insulinotropic action of L-
arginine has been ascribed to transporter-mediated accumulation of this cationic amino 
acid inside the ß-cells. The carrier-mediated entry of L-arginine into the islet B-cells, with 
resulting depolarization of the plasma membrane is suggested as the essential mechanism 
for stimulation of insulin release by this cationic amino acid.164- 165  One other putative 
mechanism is the formation of nitric oxide (NO) from L-arginine by the action of NO 
synthase in pancreatic ß-cells.166 A relationship is suggested including a synergistic 
coupling effect of L- arginine, insulin and glucose which may be significant in 
pathological states.167, 168  Arginine also exerts favorable effects in the prevention and 
treatment of endothelial damage and the restoration of endothelial function in patients 
with cardiovascular risk factors or severe chronic cardiovascular disorders. L-Arginine 
administration is likely to represent a potentially novel therapeutic strategy.169, 170 
Infusion of L-arginine in healthy subjects induces vasodilation and inhibits platelet 
aggregation and blood viscosity. These effects are mediated, in part, by endogenous 
released insulin.171  
 
Glucagon: 
Glucagon is the hormone produced by the A cells of the pancreatic islets. Its secretion is 
stimulated by hypoglycaemia. In the liver, it stimulates glycogenolysis by activating 
phosphorylase. Glucagon also enhances gluconeogenesis from amino acids and lactate. In 
all these actions, glucagon acts via generation of cAMP. Both hepatic glycogenolysis and 
gluconeogenesis contribute to the hyperglycaemic effect. 157  
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Catecholamines: 
Epinephrine and norepinepherine both cause glycogenolysis. They produce this effect via 
α- adrenergic receptors that increase cAMP, with activation of phosphorylase. In 
addition, the catecholamines increase the secretion of insulin and glucagons via β-
adrenergic mechanisms and inhibit the secretion of these hormones via α-adrenergic 
mechanisms. 
 
 Growth hormone: 
Growth hormone is diabetogenic because it increases hepatic glucose output and it 
decreases glucose uptake in muscles. The hormone secretion is stimulated by 
hypoglycaemia. 
 
Glucocorticoids 
Glucocorticoids are secreted by adrenal cortex and increase gluconeogenesis. This is a 
result of enhanced hepatic uptake of amino acid and increased activity of 
aminotransferase and key enzymes of gluconeogenesis. In addition, glucocorticoids 
inhibit the utilization of glucose in extrahepatic tissues. 
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The Objectives of the Study 
• To examine the pathophysiological aspects of severe malaria in children related to 
blood glucose homeostasis. 
• To determine possible causes of hypoglycaemia in severe malaria in children. 
• To propose appropriate laboratory tests as indicators for high risk children with 
severe malaria. 
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CHAPTER TWO 
 
PATIENTS AND METHOD 
 
 
Location and time of the study  
This is a cross- sectional cohort study examining the pathophysiology, clinical 
presentations and laboratory features of severe malaria. It was conducted at Khartoum 
paediatric and Bashaeir Hospital. The collection of the cases started from September 
2006 until September 2007.  
Patients and Controls  
All children from 0 to 12 years with Plasmodium falciparum infection with one or more 
of WHO criteria (WHO, 1990) of severe malaria were included in the study during period 
from September 2006 to September 2007. A group of 35 children age (0-12 years) with 
uncomplicated malaria was included in the study for comparison. All patients in the study 
from both severe and uncomplicated malaria groups were examined in the hospital, a full 
history, physical examination and venous blood samples were taken on admission prior to 
treatment after informed consent.  
History and Physical Examination 
A data collection form was designed and completed for both groups of severe and 
uncomplicated malaria into taking consideration the full medical history, physical 
examination and laboratory findings with reference to age, gender and residence 
(Appendix I). All malaria patients underwent a complete clinical examination with 
general and systemic examination by a medical doctor in hospital on admission.  
Laboratory Analyses 
Blood Samples  
A sample consisting of 5ml of venous blood was taken before treatment from each patient 
in both groups of children with malaria for the laboratory investigations, taking in 
 54
consideration time of the last meal. Before centrifugation 20 µl from the sample was 
taken for Hb estimation. After the separation of the Plasma by centrifugation at 3000 
rpm, plasma was transferred to a labeled plain plastic container. A 1 ml portion was used 
for measurements of K+ and RBG, the rest of the sample 2.5 ml was kept in a plane 
container, and stored at – 80C° until the end of samples collection for the measurements 
of insulin, c-peptide, and the amino acids. Hb and K+ measurement were done in the 
hospital lab immediately after taking the blood sample from the patient.  
Malaria Diagnosis 
The microscopic identification of parasites in blood is the most certain method of 
confirming infection with P. falciparum. Preparations thick and thin films staining were 
performed according to the WHO criteria (WHO, 1983). 
Procedure: Blood was taken from each child directly from the ear lobe, finger or heel of 
infant using a sterile disposable lancet. Absolute methyl alcohol is used to fix the thin 
blood films.  
A stock solution of Giemsa stain was prepared from Giemsa powder: 
• Giemsa powder                          3.8g 
• Glycerol                                     250ml 
• Methyl alcohol                            250ml 
Working solutions of Giemsa stain were diluted by mixing an appropriate amount of the 
stock with distilled neutral or slightly alkaline water. The water for dilution was kept at 
pH 7.1- 7.2 using a phosphate buffer.  
Haemoglobin Estimations(Calorimetric method)  
The basis of this method is the dilution of blood in a solution containing potassium 
cyanide and potassium ferricyanide (Drabkin’s cyanide- ferricyanide solution).  
Haemoglobin (Hb), methaemoglobin (Hi), carboxyhaemoglobin (Hbco) are all converted 
to cyanomethaemoglobin (HiCN). The absorbency of the solution is then measured in a 
colorimeter at a wavelength of 540 nm.172  
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Procedure: A 20 µl from the sample was added to 4 ml of dilution solution, the tube 
containing the solution was inverted several time. After it was allowed to stand at room 
temperature to ensure the completion of the reaction (3-5min), it was compared with the 
standard and a reagent blank in a colorimeter at wavelength 540 nm. 
Potassium Measurement: 
Potassium was measured in a plasma sample in a flame photometer using compressed air. 
The diluted plasma is sprayed as a fine mist of droplets into a non-Luminous gas flame 
which becomes colored by the characteristic blue emission of the potassium ions in the 
sample. Light of a wavelength corresponding to the metal is selected by an appropriate 
filter. The amount of colour emitted depends on the concentration of K ions present in 
mmol/l. 173 
 
Procedure: A 50 µl of the plasma was added to 10ml distilled water in a test tube before 
measurement in the flame photometer. 173 
 
 
Random Blood Glucose Measurement 
This was measured by an enzymatic colorimetric method using the glucose oxidase-
peroxidase method. Glucose oxidase catalyzes the oxidation of glucose to give hydrogen 
peroxide (H2O2) and gluconic acid. The formed H2O2 reacts under catalysis of 
peroxidase with phenol and 4-amino-antipyrine to form quinoneimine which gives a pink 
colour. The intensity of the colour is proportional to the glucose concentration in the 
sample. The absorbency of the colour produced is then measured in a colorimeter at a 
wavelength of 520 nm. 173 
 
Procedure: Three test tubes were prepared in the first tube 10µl from distilled water was 
added (Distilled water tube), in the second tube 10µl from the standard was added  
(Standard tube), 10µl from the sample was added to third test tube (Sample tube).  Pipette 
1ml from the reagent into the three test tubes. The three test tubes were mixed and 
incubated at room temperature for 30-10 minutes, and then the absorbance of the standard 
and the sample were measured against the reagent blank in a colorimeter at a wavelength 
of 520 nm. 173 
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Amino Acid Analysis 
 
Concentrations of free amino acids in plasma were measured using high performance 
liquid chromatography (HPLC) SYKAM Amino Acids Analyzer S (433) (Fig.1). The 
technique is based on cation exchange chromatography. HPLC is a form of liquid 
chromatography to separate compounds that are dissolved in solution. HPLC instruments 
consist of a reservoir of mobile phase, a pump, an injector, a separation column, and a 
detector. Compounds are separated by injecting a plug of the sample mixture onto the 
column. The different components in the mixture pass through the column at different 
rates due to differences in their partitioning behavior between the mobile liquid phase and 
the stationary phase (Fig.1). Only two or three buffer solutions have to be combined to 
form the best optimized buffer profile at any part of the separation program (Appendix 
II). 
Principle (Ninhydrine detects amino acids): Ninhydrine oxidatively decarboxylates alpha-
amino acids to CO2 NH3 and an aldehyde with one less carbon atom than the parent 
amino acid. The reduced ninhydrine then reacts with the liberated ammonia, forming a 
blue complex that maximally absorbs light of wave length 570 nm. This blue color forms 
the basis of a quantitive test for alpha-amino acid that can detect as little as 1 micro g of 
amino acid (Fig.2). 
 
Methodology: A 900 µl plasma was transferred into 1.5 eppendrof  tube from the plane 
container and  100 µl of 20% 5- sulfosalicyclic acid was added to the 900 µl of the 
plasma to precipitate the plasma proteins (proteins immediately precipitated under a clear 
supernatant), then incubated at 4°C for 30 minutes. The sample was centrifuged at 13000 
rpm for 10- 15minutes 4°C (Deproteinization was completed).The supernatant was 
carefully separated into an autosampler vial. The supernatant was diluted with sample 
diluting buffer in the ratio of 1:1. The pH of the sample should be within the range of 1.8-
2.0. After this it can be either analyzed or otherwise store frozen at – 80° C. 
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Fig (1): Reaction between the amino acid and ninhydrine 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (2): Flow chart of amino acid analyzer 
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Measurements of Insulin and C-peptide in Plasma Samples by Using 
Radioimmunoassay (RIA): Concentrations of insulin and C-peptide in plasma were 
measured using radioimmunoassay (RIA) using IMK- 414 kits (Beijing China).  The test 
was carried out in Department of Obstetrics and gynecology laboratory, faculty of 
Veterinary science, University of Khartoum.   
Principle of the (RIA): 
The radioimmunoassay method in this test depends upon the competition between iodine-
125 labeled analyte (insulin and C-peptide) and analyte in the patient sample, for the 
limited number of binding site on analyte specific antibody. After incubation for a fixed 
time, separation of labeled bound from free molecules is achieved by the Polyethylen 
Glycol (PEG-accelerated double- antibody procedure). The tube was then counted in 
gamma counter, the counts being inversely related to the amount of insulin present in the 
patient sample. By measuring the proportion of 125I-labelled insulin bound in the presence 
of varying known amounts of standard analyte, the concentration of analyte in unknown 
samples can be interpolated. 174  
 
Assay protocol of insulin (Insulin radioimmunoassay kit IMK-414)  
 
- Test tubes were labelled and arranged according to the scheme protocol 
- 100 µl of the insulin standard solutions (5, 10, 20, 40, 80, and 160 mlU/L) and the 
unknown samples were pipetted according to the scheme. 
- 100 µl of insulin antibody solution were added to all tubes except total and non 
specific bound (NSB) tubes.  
- 100  µl of iodine-125 labelled insulin solution were added  
- All test tubes were incubated at 37C for 2 hours. 
- 500 µl of the separating agent solution were pipetted to all tubes except total 
counts, then been mixed and placed at 37C for 15 minutes.  
- All assay tubes were spun using ultra centrifuge (except those for total counts) at 
1500 rpm for 15 minutes. 
- The supernatant of all tubes was decanted carefully. 
- All the tubes were counted in a gamma counter. 
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Assay protocol of C-peptide (C-peptide radioimmunoassay kit IMK-406) 
 
- The test tubes were arranged and labelled according to the scheme protocol.  
- 100 µl C-peptide standard solutions 0.2, 0.6, 1.5, 3.0, 6.0, 12.0 ng/ ml and the 
unknown samples had pipetted according to the scheme. 
- 100 µl of C-peptide antibody solution were added to all tubes except total and non 
specific binding tubes.  
- 100 µl of Iodine-125 labeled C-peptide solution was added to all tubes. 
- All test tubes were incubated at 4C for 24 hours. 
- 500 µl of the separating agent solution (second antibody for separation: Amerlex-
M donkey –anti-rabbit-reagent) was added to all tubes except total counts, then 
mixed and placed at 37C for one hour. 
- All assay tubes were spun using ultra centrifuge (except those for total counts) at 
1500 rpm for 15 minutes. 
- The supernatant of all tubes was decanted carefully. 
- All the tubes were counted in a gamma counter. 
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CHAPTER THREE 
 
RESULTS 
 
The Frequency Distribution of Severe and Uncomplicated 
Malaria 
The total number of patients with malaria included in this study and confirmed by thin and 
thick blood films examined for Plasmodium falciparum were 80 patients. The WHO 
criteria for severe malaria were used to classify malaria patients as severe or 
uncomplicated. All patients in the study (severe and uncomplicated malaria) were admitted 
to hospital. A total of 45 patients (56.25%) fulfilled the WHO criteria for severe malaria 
and will be referred to as severe malaria group, 35 patients (43.75%) constituted the 
uncomplicated malaria group who did not fulfill the WHO criteria for severe malaria 
(Table 1).  
 
Table (1): Sample characteristics  
 
 Severe malaria  Uncomplicated malaria  
Number  45 35 
Age (yr): Mean 
(range) 4.7 (1-12) 8.1 (1.5-13) 
Gender (%): 
   Male  
 
25 (55.6)  
 
22 (63) 
   Female  20 (44.4) 13 (37) 
 
 
The mean age of patients with severe malaria was 4.7years and for uncomplicated malaria 
was 8.1years, significant difference was found between the means of the age P. value = 
0.0001 (Table 1). Severe malaria affected children less than five years old compared with 
uncomplicated malaria which affected children more than five years old (Fig. 3). The 
incidence in this sample of severe malaria cases in males and females was (0.9: 1). Patients 
with severe anaemia and convulsions were young children having a mean of age 3.4 and 
4.8 years respectively , while for cerebral malaria were older children 6.1 years (Table 2). 
The presenting features of children with Plasmodium falciparum malaria on admission are 
shown in (Table 3). 
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Table (2): Mean Age of the different categories of patients with severe 
malaria.   
  
Clinical categories of severe malaria N Mean ± SD 
severe anaemia 12 3.4 ± 1.02 
cerebral malaria 13 6.1 ± 2.8 
convulsion 15 4.8 ± 2.4 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
Pe
rc
en
t %
severe malaria uncomplicated
Fig. (3): Distribution of the study population according to age 
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Table (3): Presenting features of children with Plasmodium falciparum 
malaria in descending order of frequency. 
 
Features Severe malaria(n=45) Number (%) 
Uncomplicated 
malaria(n=35) 
Number (%) 
Fever  41(91) 32 (91) 
Hyperparasitaemia 37(82.2) 28(80) 
Vomiting 34  (75.5) 25 (71) 
Headache 32 (71) 23(66) 
Loss of appetite  31(68.8) 30 (86) 
Nausea   28(62.2) 27 (77) 
Myaligia  25 (55.5) 20 (57) 
Abdominal pain 22 (48.8) 14(40) 
Convulsion   15 (33.3)   - 
Diarrhea 15 (33.3) 10(29) 
Cerebral malaria  13 (28.9)   - 
Severe anaemia  12 (26.7)   - 
Jaundice 8 (17.7) 3(8.5) 
hypovolaemia 5 (11.1)    - 
Splenomegaly 4 (8.8)    - 
Hepatomegaly 2 (4.4)    - 
Hypoglycaemia  2 (4.4)    - 
Hypotension 1 (2.2)    - 
Respiratory distress 1(2.2)    - 
 
 63
Characterization and Grouping of Patients with Severe Malaria 
The clinical presentations of patients categorized as having severe malaria are shown in 
figure 2. Convulsions were most commonly found and accounted for 33.3% of the severe 
malaria cases, followed by cerebral malaria 28.9%, 26.7% for severe anaemia and 4.4% 
for hypoglycaemia, and 6.7%  had a mixture of manifestations, more than one 
complications of severe malaria (Fig 3). The mortality rate was 5% in severe malaria 
cases (two patients with cerebral malaria died).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4): Characterization of the samples according to criteria of 
severe malaria 
Severe anaemia
26.7%
Cerebral malaria
28.9%
Convulsion
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Investigations in the Severe and Uncomplicated Malaria 
Blood Sample tests for random blood glucose, insulin, C-peptide, potassium, and 
haemoglobin are presented in table (4). Severe malaria has been categorized into severe 
anaemia, cerebral malaria, convulsion, and hypoglycaemia. The results are presented in 
table (5).  
 
Table (4): Means of RBG, insulin, C-peptide, K+ and Hb in patients of 
severe and uncomplicated malaria. 
 
Parameter Severe malaria n=45 
Uncomplicated 
malaria n=35 P. value 
RBG (mg/dl) 99.58 ± 40.8 96.18 ± 23.5 0.6 
Insulin (mIU/L)  5.31 ± 4.2  8.59 ± 5.19 0.007 
Insulin (pmol/L) 31.86 51.54 0.0001 
C-peptide (ng/ml) 0.97 ± 0.68 1.2 ± 0.84 0.2 
C-peptide(pmol/L) 269.44 333.33 0.6 
Insulin:C-peptide ratio 0.18  ±0.10  0.29 ± 0.23 0.05 
K+ (mmol/L) 3.4 ± 0.69 3.14 ± 0.5 0.07 
Hb (g/dl) 6.98 ± 2.66 9.69 ± 2.87 0.0001 
 
 
 
Blood Glucose  
 
The mean blood glucose level in patients of severe malaria was (99.58 mg/dl) while in 
uncomplicated malaria (96.18 mg/dl), no significant difference was found between 
the two groups (Table 4, Figure. 5). In the comparison of mean of RBG between the 
uncomplicated malaria and the clinical categories of severe malaria, hypoglycaemic 
patients had significantly low level of RBG P= 0.006, and cerebral malaria patients had 
the highest level of RBG as showed in table (5) but no significant difference was found. 
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Fig. (5): Mean of RBG in uncomplicated and severe malaria.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (5): Comparison of RBG between uncomplicated malaria and the 
clinical categories of the severe malaria. 
Mean(mg/dl) 
± SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean(mg/dl) ± 
SD P. value 
96.18 ± 23.5 Severe anaemia 
 
98.64 ± 30.4 0.9 
Cerebral malaria 
 
110.27 ± 
31.62 
0.3 
Convulsions 
 
102.55 ± 
50.24 
0.2 
Hypoglycaemia 
 
31.0 ± 2.82 0.006 
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Insulin 
The mean of insulin level was significantly lower in patients with severe malaria 5.31 
mlU/L, compared with the mean in the uncomplicated malaria group 8.59 mlU/L, P 
= 0.005 (Table 4, Figure.6). However, the incidence of hypoinsulinaemia (< 4mlU/ml) 
was significantly higher in severe malaria P = 0.002 (Figure 7). Hypoinsulinaemia was 
found in 22 cases (48.9%) in the severe malaria group out of 45 patients, while in 
uncomplicated malaria it was found in 5 cases (14.7%) out of 35 patients. 
 
 The insulin level in severe malaria was within the normal accepted physiological range 
for fasting patients (4-16 mlU/L).  Severe anaemic and cerebral malaria patients had 
significantly lower insulin level 5.07 and 5.05 mlU/L respectively. Hypoglycaemic 
patients had a lower mean insulin level 2.72 mlU/L compared with uncomplicated 
malaria P= 0.001(Table 6). 
 
 
Fig. (6): Mean of insulin in severe and uncomplicated malaria.   
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Fig. (7): Prevalence of hypoinsulinaemia (< 24pmol/L) in severe and 
uncomplicated malaria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P. value: 0.002 
 
 
Table (6): Comparison of insulin between uncomplicated malaria and 
the clinical categories of the severe malaria. 
Mean(mlU/L) 
± SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean(mlU/L)  ± 
SD P. value 
8.59 ± 5.19 Severe anaemia 
 
5.07 ± 2.79 0.04 
Cerebral malaria 
 
5.05 ± 3.16 0.03 
Convulsions 
 
6.04 ± 3.25 0.14 
Hypoglycaemia 
 
2.72 ± 0.67 0.001 
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C-peptide  
The mean of C-peptide was nearly equal between the two groups. The mean in severe 
malaria was 0.97 ± 0.68 ng/ml and in uncomplicated malaria it was 1.2 ± 0.84 ng/ml 
(Table 4; Figure.8). No significant differences were found between the mean of C-peptide 
in uncomplicated malaria and the clinical categories of severe malaria.  Unexpectedly, the 
difference in insulin levels was not reflected in C-peptide levels (Table 7).  
 
Fig. (8): Mean of C-peptide in severe and uncomplicated malaria.   
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Table (7):  Comparison of C-peptide between uncomplicated malaria and the 
clinical categories of the severe malaria. 
Mean 
(ng/ml)± SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean(ng/ml)± 
SD P. value 
1.2 ± 0.84 Severe anaemia 
 
1.08 ± 0.59 0.44 
 
Cerebral malaria 
 
1.06 ± 0.71 0.40 
Convulsions 
 
0.82 ± 0.74 0.22 
Hypoglycaemia 
 
0.53± 0.46 0.5 
 
 
 
Insulin: C-peptide Ratio 
 
The mean of Insulin:C-peptide ratio was significantly lower in the  severe malaria 
group (0.18± 0.13) than  uncomplicated malaria (0.29) P. value = 0.05 (Table 8). 
In the comparison of mean of I: C between the uncomplicated malaria and the 
clinical categories of severe malaria, patients with severe anaemia had significantly 
low mean I: C P. value = 0.05(Table 9). 
 
Table (8): Means of Insulin: C-peptide ratio in the severe and 
uncomplicated malaria. 
Uncomplicated 
malaria 
Severe malaria P. value 
0.29 ± 0.15 0.18 ± 0.13 0.05 
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Table (9): Comparison of Insulin: C-peptide ratio between uncomplicated 
malaria and the clinical categories of the severe malaria. 
Mean of  I:C ± 
SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean of  I:C ± 
SD P. value 
0.29 ± 0.15  Severe anaemia 
 
0.15 ± 0.07 0.05 
Cerebral malaria 
 
0.17 ± 0.11 0.1 
Convulsions 
 
0.22 ± 0.16 0.2 
Hypoglycaemia 
 
0.16 ± 0.11 0.4 
 
 
 
Correlation Between RBG and Insulin 
 
 Significant correlation was found between RBG and insulin in severe and uncomplicated 
malaria groups (Figure 9 and 10) P = 0.01 in both. Two cases of hyperinsulinaemia (36 
and 24 mIU/L) were observed in the severe malaria group and they did not show 
hypoglycaemia as their RBG levels were 133 and 95 mg/dl respectively (Fig.7). A case of 
hyperinsulinaemia was excluded from the study insulin (144 mIU/L and glucose 233 
mg/dl), which was considered as an anomalous result especially taking into consideration 
that the patient was a 4 months old baby who was the only under 1 years old.  
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Fig. (9): Correlation between Insulin and RBG in 
 Severe malaria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P.value: 0.01 
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Fig. (10): Correlation between Insulin and RBG in 
 Uncomplicated malaria. 
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Correlation Between Insulin and C-peptide 
 
Significant correlation between C-peptide and insulin was found in the two groups of 
malaria, for severe malaria group P = 0.002 (Figure. 11) and for uncomplicated malaria 
group P = 0.05 (Figure. 12). 
 
Fig. (11): Correlation between insulin and c-peptide 
 In severe malaria in molar unit. 
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Fig. (12): Correlation between insulin and C-peptide 
In uncomplicated malaria in molar unit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P.value: 0.05 
 
Potassium  
Both groups showed low plasma potassium levels. The mean potassium was 3.4 mmol/L 
in patients with severe malaria and 3.1mmol/L in patients with uncomplicated malaria, no 
significant difference was found between the two means (Table 4, Figure.13). However, 
the incidence of hypocalcaemia (< 3.5mmol/L) was significantly higher in uncomplicated 
malaria P= 0.03. Hypokalaemia was found in 25 cases (55.6%) out of 45 severe malaria 
patients. In uncomplicated cases hypokalaemia was found in 28 (80%) out of 35 patients. 
No cases of hyperkalaemia were found in the study. No significant differences were 
found between uncomplicated malaria and the clinical categories of severe malaria 
in the mean potassium levels (Table 10). No significant correlation was found between 
insulin and potassium. 
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Fig. (13): Mean of K+ in severe and uncomplicated malaria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (10): Comparison of Potassium between uncomplicated malaria 
and the clinical categories of the severe malaria. 
Mean of K+ 
(mmol/L)± SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean 
(mmol/L)± SD P. value 
 
 
 
 
3.1 ± 0.5 
Severe anaemia 
 
3.48 ± 0.93 0.1 
Cerebral malaria 
 
3.38 ± 0.71 0.2 
Convulsions 
 
3.39± 0.54 0.3 
Hypoglycaemia 
 
3.65± 0.64 0.1 
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Blood Urea Nitrogen (BUN) 
 
No significant difference was found for the mean of blood urea nitrogen (BUN) between 
the severe and uncomplicated malaria groups as shown in table (11). In these patients 
both means of severe and uncomplicated malaria are within the normal range of 2500- 
7500 µmol/l. The mean BUN urea in severely anaemic patients was significantly lower 
than that in uncomplicated malaria P value = 0.001; while the mean BUN was 
significantly higher in hypoglycaemia cases despite the fact that their number was very 
small table (12).  
 
 
Table (11): Means of BUN in the severe and uncomplicated malaria 
parameter Severe malaria Uncomplicated malaria P. value 
Urea 
(µmol/l) 
1988.75 ± 
977.25 
2346.1 ± 892.47 0.1 
 
 
Table (12): Comparison of BUN between uncomplicated malaria and 
the clinical categories of the severe malaria.  
Mean ± SD 
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean ± SD P. value 
2350.6 ± 849.3 Severe anaemia 1292.5 ±  615.8 0.001 
Cerebral malaria 2862.9 ± 1286.8 0.08 
Convulsions 2063.1± 1278.6 0.6 
Hypoglycaemia 4300.6 ± 1339.8 0.002 
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Haemoglobin 
There was a highly significant difference between mean of Hb in severe 6.9 g/dl and 
uncomplicated malaria 9.6 g/dl with P = 0.0001(Figure.14). This is expected as Hb was 
used to define severe malaria. In the clinical categories of the sever malaria, severe 
anaemic and convulsions patients had significantly lower mean level of haemoglobin 
compared with uncomplicated malaria (Table 13). One observation worth noting is that 
cases with convulsions showed significantly lower mean haemoglobin levels (P=0.02) 
than the cases of cerebral malaria. 
 
 
 
 
 
Fig. (14): Mean of Hb in severe and uncomplicated malaria.   
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Table (13): Comparison of haemoglobin between uncomplicated 
malaria and the clinical categories of the severe malaria. 
Mean(g/dl)± 
SD  
Uncomplicated 
malaria 
Clinical 
categories of 
severe malaria 
Mean (g/dl)± SD P. value 
9.8 ± 2.8 Severe anaemia 4.73 ± 1.17 0.0001 
Cerebral malaria 9.06 ± 2.85 0.5 
Convulsions 7.39 ± 2.11 0.02 
Hypoglycaemia 6.35 ± 1.2 0.1 
 
Amino Acids Results 
Significant differences were found between the severe malaria and uncomplicated 
malaria in these amino acids: Taurine (Tau), Citrulline (Cit), Lysine (lys), and 
Phenylalanine (Phe). Taurine was significantly higher in the severe malaria group than 
uncomplicated malaria group while Citrulline and Lysine were significantly lower in the 
severe malaria group than uncomplicated malaria as shown in table (14).  
As arginine was taken as an indicator to the nitric oxide (NO) in this study, no significant 
difference was found between the severe malaria group (25.63 µmol/l) and 
uncomplicated malaria group (29.79µmol/l) as shown in table (14).  
Significant difference was found in Phenylalanine (P value=0.001), which had the 
highest mean in severe malaria group compared with uncomplicated malaria. So patients 
of severe malaria had elevated plasma phenylalanine (hyperphynelalaninemia). 
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Table (14): Plasma Amino acids levels.        
Amino acid (µmol/l) Uncomplicated malaria  Severe malaria  P. value 
Taurine (Tau)                 36.65  ± 13.53 47.21 ± 23.7 0.01 
Threonine (Thr) 35.88 ± 14.13 33.93 ± 16.29 0.5 
Serine (Ser) 41.6 ± 12.9 40.8± 14.1 0.8 
Asparagine  (Asn)  41.89 ± 21.19 47.86 ± 23.51 0.5 
Glycine (Gly) 62.79 ± 16.07 73.12 ± 31.76 0.1 
Alanine (Ala) 117.84 ± 48.88 112.08 ± 59.07 0.9 
Citrulline (Cit) 18.25 ± 6.42 9.81 ± 5.63 0.01 
Valine (Val) 90.87  ± 51.46 95.09 ± 54.59 0.6 
Cysteine (Cys)     13.32 ± 8.27 14.65 ± 8.06 0.3 
Methionine (Met) 12.41 ± 7.7 18.69 ± 10.1 0.2 
Isoleucine (Ile) 29.75 ± 14.8 34.31 ± 21.84 0.2 
Leucine (Leu)  70.95 ± 28.93 70.39 ± 41.37 0.8 
Tyrosine (Tyr)   28.92 ± 12.6 33.8 ± 17.07 0.2 
Phenylalanine (Phe) 67.67 ± 34.8 89.89 ± 34.83 0.01 
Lysine (lys)      44.02 ± 27.63 22.78 ± 12.63 0.001 
Histidine (His)     47.75 ± 17.63 47.44 ± 22.48 0.5 
Tryptophane (Trp) 70.12 ± 37.54 71.82 ± 49.41 0.9 
Arginine (Arg) 29.79± 12.76 25.63 ± 11.4 0.4 
Ornithine (Orn) 37.16 ± 20.56 26 ± 13.59 0.07 
Aspartate (Asp) 4.86 ± 7.3 4.24± 7.34  0.7 
Glutamate (Glu) 57.21 ± 24.78 28.84 ± 57.21 0.3 
 
 
Amino Acids in Categories of the Severe Malaria 
For clinical categories of severe malaria, note that the categories show different amino 
acids responses. Comparison between each category and uncomplicated malaria were 
made as follow:  
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Severe anaemia: 
 Differences were found in Alanine, Valine, Leucine, and Arginine which were 
significantly lower than in uncomplicated malaria patients. Ornithine was significantly 
higher in severe anaemia (Table 15). An observation worth noting is that arginine was 
significantly lower in severe anaemia cases (P=0.02)  
 
Table (15): Comparison between the mean of amino acids in 
uncomplicated malaria and severe anaemia. 
Amino acid (µmol/l) Uncomplicated 
malaria 
Severe anaemia P. value 
Taurine (Tau)                      36.65  ± 13.53 31.01 ± 8.08 0.2 
Threonine (Thr) 35.88 ± 14.13 25.90 ± 10.3 .05 
Serine (Ser) 41.6 ± 12.9 35.87 ± 9.75 0.2 
Asparagine  (Asn)  41.89 ± 21.19 45.75 ± 25.9 0.7 
Glycine (Gly) 62.79 ± 16.07 57.77 ± 20.24 0.3 
Alanine (Ala) 117.84 ± 48.88 76.83 ± 30.47 0.02 
Citrulline (Cit) 18.25 ± 6.42 11.65± 3.8 0.2 
Valine (Val) 90.87 ± 51.46 58.71 ± 26.53 0.04 
Cysteine (Cys)     13.32 ± 8.27   9.50  ± 2.37 0.2 
Methionine (Met) 12.41 ± 7.7  13.59 ± 7.87 0.5 
Isoleucine (Ile) 29.75 ± 14.8 21.86 ± 11.19 0.2 
Leucine (Leu)  70.95 ± 28.93 41.36 ± 15.33 0.007 
Tyrosine (Tyr)   28.92 ± 12.6 24.92 ± 5.8 0.4 
Phenylalanine (Phe) 67.67 ± 34.8 78.96 ± 33.3 0.1 
Lysine (lys)      44.02 ± 27.63 21.91 ± 13.66 0.04 
Histidine (His)     47.75 ± 17.63 37.79 ± 14.9 0.1 
Tryptophane (Trp) 70.12 ± 37.54  71.60 ± 30.5 0.7 
Arginine (Arg) 29.79± 12.76 19.30 ± 6.91 0.02 
Ornithine (Orn) 37.16 ± 20.56 27.48 ± 13.86 0.03 
Aspartate (Asp) 4.86 ± 7.3 4.63 ± 7.95 0.4 
Glutamate (Glu) 57.21 ± 24.78 16.56 ± 21.98 0.3 
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Cerebral malaria: 
In this category the most significant change was found in Phenylalanine, Taurine and 
glycine (Table 16). The large neutral amino acids {Valine (Val), Methionine (Met), 
Histidine (His), Isoleucine (Ile), Lysine (lys), Tyrosine (Tyr), Leucine (Leu)} which 
were significantly higher in patients with cerebral malaria compared with 
uncomplicated malaria (except for Tryptophane which didn't show a significant 
difference). 
 
Table (16): Comparison between the mean of amino acids in 
uncomplicated malaria and cerebral malaria. 
Amino acid (µmol/l) Uncomplicated malaria Cerebral malaria P. value 
Taurine (Tau)                 36.65  ± 13.53 66.72 ± 30.1 0.0001 
Threonine (Thr) 35.88 ± 14.13 43.81 ± 17.12 0.06 
Serine (Ser) 41.6 ± 12.9 48.53  ± 15.2 0.07 
Asparagine  (Asn)  41.89 ± 21.19 40.8± 15.2 0.8 
Glycine (Gly) 62.79 ± 16.07 94.24 ± 37.32 0.001 
Alanine (Ala) 117.84 ± 48.88 134.92  ± 56.5 0.2 
Citrulline (Cit) 18.25 ± 6.42 10.66  ± 6.64 0.3 
Valine (Val) 90.87 ± 51.46 131.44 ± 65.96 0.03 
Cysteine (Cys)     13.32 ± 8.27 16.21 ± 8.82  0.3 
Methionine (Met) 12.41 ± 7.7 29.73 ± 9.5 0.02 
Isoleucine (Ile) 29.75 ± 14.8 50.06 ± 23.15 0.001 
Leucine (Leu)  70.95 ± 28.93 96.12 ± 39.55 0.01 
Tyrosine (Tyr)   28.92 ± 12.6 45 ± 24.26 0.004 
Phenylalanine (Phe) 67.67 ± 34.8 112.86 ± 40.01 0.0001 
Lysine (lys)      44.02 ± 27.63 22.8 ± 11.54 0.04 
Histidine (His)     47.75 ± 17.63 61.52 ± 14.19 0.01 
Tryptophane (Trp) 70.12 ± 37.54 70.31 ± 54.61 0.8 
Arginine (Arg) 29.79± 12.76 28.82 ± 11.98 0.9 
Ornithine (Orn) 37.16 ± 20.56 17.73 ± 6.52 0.9 
Aspartate (Asp) 4.86 ± 7.3 5.02± 8.14 0.5 
Glutamate (Glu) 57.21 ± 24.78 38.4± 70.32 0.1 
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Convulsions: 
In this category, the only significant difference was found in phenylalanine which was 
higher than in uncomplicated malaria as shown in table (17). However, its level was 
much lower than in cerebral malaria. Unlike cerebral malaria, convulsions patients did 
not show elevated level in the large neutral amino acids.  
 
Table (17): Comparison between the mean of amino acids in 
uncomplicated malaria and convulsions.  
Amino acid (µmol/l) Uncomplicated malaria Convulsions P. value 
Taurine (Tau)                   36.65  ± 13.53 43.72 ± 15.08  0.09 
Threonine (Thr) 35.88 ± 14.13 30.8 ± 13.98 0.4 
Serine (Ser) 41.6 ± 12.9 38.52 ± 14.51 0.7 
Asparagine  (Asn)  41.89 ± 21.19 48.73 ± 23.5 0.5 
Glycine (Gly) 62.79 ± 16.07 61.00  ± 20 0.6 
Alanine (Ala) 117.84 ± 48.88 116.18 ± 61.52 0.9 
Citrulline (Cit) 18.25 ± 6.42 11.10 ± 6.16 0.2 
Valine (Val) 90.87 ± 51.46 95.65 ± 54.41 0.7 
Cysteine (Cys)     13.32 ± 8.27 15.57 ± 6.00 0.3 
Methionine (Met) 12.41 ± 7.7 13.60 ± 5.80 0.4 
Isoleucine (Ile) 29.75 ± 14.8 35.45 ± 21.7 0.2 
Leucine (Leu)  70.95 ± 28.93 73.33 ± 45.45 0.6 
Tyrosine (Tyr)   28.92 ± 12.6 31.50 ± 12.09 0.3 
Phenylalanine (Phe) 67.67 ± 34.8 85.03 ± 30.17 0.03 
Lysine (lys)      44.02 ± 27.63 30.24 ± 17.52 0.2 
Histidine (His)     47.75 ± 17.63 46.80 ± 20.53 0.9 
Tryptophane (Trp) 70.12 ± 37.54 72.26 ± 30.6 0.7 
Arginine (Arg) 29.79± 12.76 30 ± 12.11 0.9 
Ornithine (Orn) 37.16 ± 20.56 32.2 ± 16.8 0.2 
Aspartate (Asp) 4.86 ± 7.3 4.36 ± 7.68 0.7 
Glutamate (Glu) 57.21 ± 24.78 30.29 ± 51.48 0.2 
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`Hypoglycaemia: 
Hypoglycaemia was found only in two patients (4.4%). A significant increase was 
found for Glycine, Alanine, Cysteine, Leucine, Tyrosine, and Phenylalanine in 
hypoglycaemic patients compared with uncomplicated malaria. All these amino acids 
are glucogenic, except for leucine which is ketogenic. Hypoglycaemic patients also had 
the highest level of Alanine among the clinical categories of the severe malaria 212 
µmol/l (Table 18). 
 
Table (18): Comparison between the mean of amino acids in 
uncomplicated malaria and hypoglycaemia. 
Amino acid (µmol/l) Uncomplicated 
malaria 
Hypoglycaemia P. value 
Taurine (Tau) 36.65  ± 13.53 53.13 ± 17.14 0.06 
Threonine (Thr) 35.88 ± 14.13 50.27 ± 26.5 0.1 
Serine (Ser) 41.6 ± 12.9 43.34 ± 19.33 0.7 
Asparagine  (Asn) 41.89 ± 21.19 82.00 ± 20.5 0.1 
Glycine (Gly) 62.79 ± 16.07 97.72 ± 58.39 0.02 
Alanine (Ala) 117.84 ± 48.88 212 ± 53.74 0.006 
Citrulline (Cit) 18.25 ± 6.42 0 ± 0 0.4 
Valine (Val) 95.53 ± 51.46 150.43 ± 20.6 0.09 
Cysteine (Cys) 13.32 ± 8.27 27.78  ± 14.46 0.02 
Methionine (Met) 12.41 ± 7.7 12.02 ± 6.64 0.8 
Isoleucine (Ile) 29.75 ± 14.8 28.93 ± 19.31 0.9 
Leucine (Leu) 70.95 ± 28.93 117.15  ±  28.07 0.01 
Tyrosine (Tyr) 28.92 ± 12.6 43.45 ± 9.67 0.05 
Phenylalanine (Phe) 67.67 ± 34.8 112.3 ± 27.29 0.02 
Lysine (lys) 44.02 ± 27.63 11.87 ±  2.2 0.1 
Histidine (His) 47.75 ± 17.63 42.52 ± 18.53 0.6 
Tryptophane (Trp) 70.12 ± 37.54 50.44 ± 10.11 0.5 
Arginine (Arg) 29.79± 12.76 21.51 ± 4.94 0.6 
Ornithine (Orn) 37.16 ± 20.56 14.3 ± 6.4 0.6 
Aspartate (Asp) 4.86 ± 7.3 0.35 ± 0.4 0.4 
Glutamate (Glu) 57.21 ± 24.78 14.7  ±  20.78 0.8 
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Glucogenic Plasma Amino Acids Levels 
No significant difference was found between the mean values of children with severe 
malaria and uncomplicated malaria) in glucogenic plasma amino acid levels {Alanine 
(Ala), Arginine (Arg), Cysteine (Cys), Glycine (Gly), Methionine (Met),  Serine (Ser), 
Threonine (Thr), Valine (Val), Isoleucine (Ile), Phenylalanine (Phe), Histidine (His) 
Tryptophane, (Trp), Tyrosine (Tyr), Asparagine (Asn), Glutamate (Glu), and Aspartate 
(Asp)}. However for Phenylalanine, which was higher in the severe malaria group (Table 
14). The sums of the glucogenic amino acids were measured for the both groups of the 
study, for the severe malaria group it was 772.19 µmol/l and for uncomplicated malaria it 
was 757.63 µmol/l.  
 
Glucogenic plasma amino acids levels in the clinical categories of severe malaria: 
Figure (15) showed elevated plasma concentrations of Alanine (hyperalaninaemia), 
Valine, Cystine and Asparagine in hypoglycaemic patients compared with the other 
categories. High incidence of glucogenic amino acids (Alanine, valine, Phenylalanine 
and Glycine) were found in children with cerebral malaria and hypoglycaemia (P. value 
= 0.01 and 0.04 respectively) 
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Large Neutral Amino Acid Levels 
Large neutral amino acids were significantly higher in patients with cerebral malaria than 
the other categories of severe malaria as shown in figure (16). Note that the mean levels 
for convulsions and uncomplicated malaria were nearly equal to each other.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (16): Large neutral amino acid level in clinical categories 
of severe malaria
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Results of Jaundice Cases  
There are 8 cases of jaundice in the study, 6 cases in the severe malaria and 2 in 
uncomplicated malaria. Means of Hb, insulin, C-peptide, K, and arginine were compared 
for these cases.  As shown in table (19) they have severe anaemia and hypoinsulinaemia. 
 
Table (19): Means of Hb, Insulin, C-peptide, K, and arginine in 
jaundice cases. 
Hb  
(g/dl) 
K+ 
 (mmol/L) 
Insulin  
(mlU/L) 
C-peptide 
 (ng/ml) 
Arginine  
(µmol/l) 
4.8 3.3 ± 0.7 3.3 ±0.6 0.6 ± 0.5 23.7 ± 10.2 
 
 
Fatality Cases in the Study  
Two patients with cerebral malaria died. As shown by table (20) patient (1) had low: 
RBG, insulin, C-peptide and high levels of alanine while patient (2) did not show this 
difference compared with severe and uncomplicated malaria. An observation worth 
noting is that blood urea nitrogen was high in these two patients compared with severe 
and uncomplicated malaria. 
 
Table (20): Means of Hb, RBG, and insulin for fatality cases  
 
Age(years)/sex 
Hb 
(g/dl) 
RBG 
(mg/dl) 
Insulin 
(mlU/L) 
C-peptide 
(ng/ml) 
K 
(mmol/l) 
BUN 
µmol/l 
Alanine 
µmol/l 
Phenyl
alanine 
Arginine 
1-7years/male 
(coma) 
6 59 3 0.7 2.7 5521 226 70 52 
2-6years/male 
(coma) 
6 94 8 2.2 3.2 6302 134 65 28 
Severe malaria 6.98 99.58 5.31 .97 3.4 1988.75 112.08  89.89 25.63 
Uncomplicated 
malaria 
9.69 96.18 8.59 1.2 3.14 2346.1 117.84 67.67 29.79 
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CHAPTER FOUR 
DISCUSSION 
Age Distribution of the Disease 
 
In this study, severe malaria affected the lower age group (less than 5 years), while 
uncomplicated malaria affected the upper age group (more than five years of age). 
Compared with study of Giha et al in 2005 26 had found that young children aged 2 to 4 
years constituted a much higher percentage among patients with severe malaria.   
In regions holo-or hyperendemic for malaria, the greatest burden is borne by children less 
than five years of age, whereas in areas of low endemicity, the disease affects all age 
groups. Most of the patients in this study (70%) came from Mayo village and peripheral 
camps in Khartoum state, which may be considered a holoendemic area, unlike the centre 
of the city which is hypoendemic area. The rest of the patients came from other states to 
Khartoum for medical care.  
There are important differences in the clinical spectrum of severe malaria with age.4, 
10,24,26 In this study, the mean age for severe anaemia and convulsion was 3.4 years and 
4.8 years respectively, while cerebral malaria affected the group of children with a mean 
age 6.1 years of age. The manifestations of severe malaria differ depending on the age of 
the patient and previous exposure. In the first 3 years of life severe anaemia and seizures 
are a common presenting feature of severe malaria and in older children cerebral malaria 
predominates. This data suggested that, the difference in the age distribution of the 
different complications was of special importance as a risk indicator.   
 
Glucose Homeostasis 
Random Blood Glucose 
No significant difference was found in RBG on admission between severe malaria (99.6 
mg/dl) and uncomplicated malaria (96.2 mg/dl). Normoglycaemia was common at 
admission among children in this study not hypoglycaemia as it was expected. In this 
study, hypoglycaemia was an uncommon complication, it was found only in two patients, 
who represent 4.4% of patients of severe malaria. Hypoinsulinaemia (insulin less than 4 
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mlU/ml) accompanies hypoglycemia in this study. In hypoglycaemic patients insulin 
mean was (2.7 mlU/ml), C-peptide was also low (0.56) but no significance was found.  
This study has shown that hypoglycaemia was uncommon in cases of severe malaria. The 
causes of hypoglycemia in African children with malaria are incompletely understood. 
Hyperinsulinemia rarely accompanies hypoglycaemia in children presenting to hospitals 
with severe malaria, although hyperinsulinemia can complicate the treatment of children 
who receive quinine.100, 175 
   
The present data indicate instead of a decrease in glucose production, there is normal 
glucose production in almost all patients with severe malaria and uncomplicated malaria. 
This agrees with studies which reported that glucose production and gluconeogenesis are 
often increased in falciparum malaria (complicated and uncomplicated malaria). The 
most striking finding has been that the increase in glucose production in falciparum 
malaria is due to a rise in gluconeogenesis.111, 113, 114  
  
Infection with Plasmodium falciparum induced a significant increase in glucose 
production and gluconeogenesis.111, 113, 114 Glucose production was increased by 100% in 
adult patients with cerebral malaria.111, 107 In children, glucose production was also much 
higher in severe malaria than in uncomplicated infection.107, 176 In this study no 
hypoglycaemia was found in severe malaria patients which can readily be explained by 
the lower insulin levels which favor gluconeogenesis. Most of the patients in this study 
were normoglycaemic which indicate increase glucose production rather than decrease. 
Insulin: C-peptide Ratio 
The mean of Insulin: C-peptide ratio was significantly lower in severe malaria (0.18 
mlU/ml)compared with uncomplicated malaria (0.29 mlU/ml). Also the incidence of 
hypoinsulinaemia was significantly higher in severe malaria. This result indicates lower 
insulin level in patients with severe malaria. It is reported that peripheral delivery of 
insulin is not in equlmolar quantities to those of C-peptide. The value is usually 1/5 of the 
C-peptide delivered. Table (21) blow shows the expected values in the peripheral 
circulation. The expected value of insulin is normal in the uncomplicated malaria group 
while it is significantly low in the severe malaria group.   
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Table (21):  Expected values of insulin in severe and uncomplicated malaria  
 
 
 
 
 
 
 
It can be concluded that there is a decrease in the half- life of insulin in the peripheral 
circulation in children with severe malaria. The mechanism by which this takes place 
remains to be elucidated. Implications of decreased half-life may be due to increased 
insulin uptake by the liver or muscles or some other factors which may lead to 
degradation or interference with the measurements of insulin in the peripheral blood. 
 
Hypoglycaemia 
English104 et al in 1998 investigated the pathophysiology of hypoglycaemia in severe 
malaria in Kenya. Of 171 children with severe malaria, 16% were hypoglycaemic on 
admission, 9% of the children had a definite episode of hypoglycaemia after admission. 
Blood levels of gluconeogenic precursors (alanine, lactate and glycerol) were higher in 
those with either hypoglycaemia on or after admission. They support the hypothesis that 
gluconeogenesis is impaired.104 Furthermore, although alanine infusion has been 
observed to increase glucose production and plasma glucose in children with mild 
malaria with a low plasma glucose (<3.5 mmol/l), 177 the high alanine levels were taken 
to indicate that further alanine administration is unlikely to increase blood glucose in 
children with severe malaria and hypoglycaemia. On the contrary, these data suggest that 
the handling of gluconeogenic precursors is disturbed in severe malaria, in contrast to the 
situation in mild malaria. 176  
 
It is interesting therefore that hypoglycaemia tends to occur in children who are more 
acidotic and who have greater evidence of renal impairment. Acidosis is known to inhibit 
hepatic uptake of lactate at high concentrations (>2 mmol/l) and to impair 
gluconeogenesis. Alanine would normally enter the gluconeogenic pathway at the same 
Parameter Severe malaria n=45 Uncomplicated malaria n=35 
Insulin pmol/l 
 
31.86 51.54 
C-pepetide pmol/l 269.44 333.33 
Expected value of insulin  53.88 66.66 
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level as lactate, and its metabolism would therefore be subject to similar inhibitory 
influences. The kidney on the other hand, partly compensates for this reduction in hepatic 
metabolism of lactate under conditions of acidosis with an increase in fractional lactate 
uptake. Such a compensatory mechanism may be lost if renal function is impaired. 104  
This study reports two cases of hypoglycaemia (4.4%) in the severe malaria group. Both 
cases had high alanine levels which agree with the above findings. However English and 
et al did not measure insulin levels. No evidence of renal dysfunction and acidosis were 
found in this study, in contrast to English104 who found that hypoglycaemia tends to 
occur in children who are more acidotic and have greater evidence of renal impairment.  
Taylor99 et al in 1988 studied 95 Malawian children with falciparum malaria who were 
treated with intravenous quinine. Nineteen patients had hypoglycaemia before treatment.  
Hypoglycaemia was associated with low plasma insulin concentrations and with elevated 
plasma concentrations of lactate, alanine, and 5'-nucleotidase a finding that suggests that 
impaired hepatic gluconeogenesis was the cause of pretreatment hypoglycaemia; and not 
hyperinsulinaemia.99 These findings are in agreement with these of the two cases 
hypoglycaemia reported in this study. However the incidence of hypoglycaemia was 
much lower (4.4%) in this study in comparison with 20% in Malawian children. Osier103 
et al in 2003 found 7.3 % of hypoglycaemia on admission in Kenyan non- neonate 
compared to 23% of hypoglycaemia on admission in neonate.103  
The mean alanine levels in this study were not different when comparing severe malaria 
and uncomplicated malaria. This indicates that there is no impairment of gluconeogenesis 
in the two groups. However, alanine was significantly higher in hypoglycaemic patients 
212 µmol/l with P=0.006 compared with uncomplicated and the other clinical categories 
of severe malaria. As it is a substrate for gluconeogenesis, this observation does not 
support a role for reduced gluconeogenic substrate supply in the pathogenesis of 
hypoglycaemia in severe childhood malaria. It is more in favor of the hypothesis that 
gluconeogenesis is impaired. Although this is in agreement with the findings of other 
studies, the numbers of hypoglycaemic patients was too small to draw any conclusion.  
Therefore the low levels of insulin are consistent with normal blood glucose and 
unimpaired gluconeogenesis. Other studies in adult showed hypoglycaemia associated 
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hyperinsulinaemia.100, 102, 105 These results indicate that different mechanisms of glucose 
homeostasis exist in adult compared to children. 
Cerebral Malaria 
Molyneux62et al in 1989 studied the clinical features and prognostic indicators in 
Malawian children admitted with cerebral malaria. Their laboratory findings of 
prognostic significance were hypoglycaemia, leucocytosis, hyperparasitaemia, elevated 
plasma concentrations of alanine and 5'–nucleo–tidase, and elevated plasma or 
cerebrospinal fluid lactate.62  
Thien111 et al in 2001 have measured glucose production and gluconeogenesis after an 
overnight fast in seven adult patients with cerebral malaria after 20 h of fasting. The 
plasma glucose concentration in the patients was 42% higher than in the healthy controls. 
Cerebral malaria is associated with increases rather than decreases in plasma glucose, 
glucose production and gluconeogenesis. Plasma concentrations of glucoregulatory 
hormones were not different between patients and controls, except for cortisol. High 
plasma cortisol may stimulate gluconeogenesis in humans. The five-fold increase in 
plasma concentration supports the idea of a major role for cortisol in the stimulation of 
gluconeogenesis in patients with malaria. They concluded that cerebral malaria stimulates 
glucose production to a greater extent than other forms of malaria. Remarkably, 
hypoglycaemia was absent; which suggested that other factors than malaria may be 
involved in the pathogenesis of malarial hypoglycaemia. Additional factors must be 
involved in the induction of hypoglycaemia in cerebral malaria. Severe anaemia, 
prolonged starvation, or malnutrition are provoking possibilities.111  
In this study, patients with cerebral malaria had a higher mean glucose 110mg/dl among 
the other categories but the difference was not significant.  No cases of hypoglycaemia 
were found among patients with cerebral malaria. These results suggest that cerebral 
malaria is associated with increased rather than decreased plasma glucose. As the alanine 
levels was not significantly higher in cerebral malaria cases (134.92 µmol/l), compared 
with uncomplicated malaria, this may be taken to indicate that gluconeogenesis was not 
impaired in these children.  
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Serum Electrolytes and Urea 
Potassium 
Acidosis is now recognized as an important component of the severe malaria syndrome 
and a predictor of fatal outcome. Alterations in plasma potassium concentrations are 
commonly associated with acidosis. To date, there is little information about the changes 
in potassium in severe malaria.178  
Maitland178 et al in 2004 reported that hypokalemia was a common complication of 
severe malaria. However, it is often not apparent on admission. On correction of acidosis, 
plasma potassium decreases precipitously and thus careful, serial monitoring of serum 
potassium is suggested in patients with severe malaria complicated by acidosis.  
Sowunmi178 in 1996 assessed renal function in African children with acute falciparum 
malaria. Plasma potassium was significantly higher and fractional potassium excretion 
significantly lower during the acute illness than after recovery. 
 
Both groups severe and uncomplicated malaria in this study showed low mean plasma 
potassium levels on admission. The mean potassium was nearly similar in patients with 
severe malaria (3.4 mmol/L) to that in patients with uncomplicated malaria (3.1 mmol/L), 
no significant difference was found. The incidence of hypokalaemia was significantly 
higher in uncomplicated malaria P value = 0.03. No cases of hyperkalaemia were found 
in the study. Hypokalaemia (potassium <3 mmol/L) is a common complication of severe 
malaria on admission in this study, especially in severe anaemia and cerebral malaria 
both of which showed higher incidence of hypokalaemia. Potassium level did not 
correlate with random blood glucose and insulin level.  
 
Maitland180 et al in 2005 concluded that most electrolytes disorders develop after 
admission and showed plasma levels that decreased below normal limits. 
Hypomagnesaemia, hypophosphatemia, and hypokalemia were common on the day after 
admission. They suggested that potassium supplementation should be prescribed only 
after correction of volume deficits 18 h after admission, and should be considered for 
most children with severe malaria 24 hours after admission. 
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In this study, the high incidence of hypokalaemia at the time of admission in severe 
malaria (55.6%) does not agree with findings of Maitland et al in 2005180 in Kenyan 
Children with Severe Malaria. They found severe hyperkalaemia at admission (16%), 
hypokalaemia was uncommon but developed in >30% of children within 24 hours after 
admission. It is important that measurement of K should be done on freshly collected 
samples as storage may lead to leakage of K from RBCs and therefore falsely high 
results. Normal blood glucose and the low level of potassium indicate normal insulin 
activity compared to findings on Kenyan children who showed hyperglycaemia and 
hyperkalaemia on admission suggesting some form of insulin resistance.  
Hypokalaemia is known to lead to cardiac arrhythmias, hypotonia, lethargy, and death.  
Also it may be an important contributor to late mortality in severe malaria. The present 
findings on serum potassium suggested that hypokalaemia which found in children with 
severe malaria may lead to complication especially in those with severe anaemia and 
cerebral malaria. 
Urea 
 Bonedio181 et al in 1989 and Poole182 in 1990 reported that serum urea does not indicate 
hydration status and suggests that serum bicarbonate was useful for detection of moderate 
to severe dehydration. MacKenzie183 et al in 1989 evaluated 102 acutely dehydrated 
children, and found that  high urea, low pH and a large base deficit,  as well as decreased 
peripheral perfusion, deep dehydration. On the other hand, Yilmaz184 et al in 2002 
suggested that serum urea and bicarbonate concentrations can be helpful in the estimation 
of fluid deficit independently from serum sodium concentration, and may be considered 
to be adjuncts to clinical evaluation in assessing the degree of dehydration.184   English85 
et al in 1996 found children with severe malaria who were dehydrated on admission. 
These children had high plasma urea concentrations (6000 v 4500 µmol/l) and were more 
acidotic than children who were not dehydrated.85  
English85 and et al in 1996 investigated the cause of hyponatraemia in severe childhood 
malaria, it was found to be correlate with age, lower urea, higher haemoglobin and blood 
glucose. Their results suggested that hyponatraemia was probably due to appropriate 
rather than inappropriate hormonal response to the loss of fluid and electrolytes in sweat, 
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vomiting, and diarrhea in children treated at home with fluids containing little 
electrolytes.85  
 
No significant difference was found in the present study for the mean of urea between the 
severe (2168 µmol/l) and uncomplicated malaria (3346.2 µmol/l) groups which were 
within the normal physiological range. However severely anaemic patients had 
significantly lower level of urea (1292 µmol/l) compared with the other categories of 
severe malaria P=0.001. The two hypoglycaemic patients showed highly significant 
mean urea compared with uncomplicated malaria P=0.002. 
 
The two cases with the highest level of urea in this study were the two cases with fatal 
outcome (5521 and 6302 µmol/l). This suggests renal failure as the most the most 
probable cause of death. A raised serum creatinine or urea with severe malaria probably 
reflects reduction in circulating fluid volume leading to pre- renal impairment. 85  
Amino acids in severe and Uncomplicated Malaria: 
Significant differences were found between the severe malaria and uncomplicated malaria 
in these amino acids: Taurine (Tau), Citrulline (Cit), Lysine (lys), and Phenylalanine (Phe). 
Taurine was significantly higher in the severe malaria group (47.21µmol/l) than 
uncomplicated malaria group (36.65µmol/l) P=0.01, while Citrulline and Lysine were 
significantly lower in the severe malaria group than uncomplicated malaria. 
Not all the severe malaria cases are similarly affected in their amino acids patterns or 
levels. Alanine was lower in cases of anaemia. The cases with cerebral malaria showed 
higher levels of amino acids while there with severe anaemia showed the lowest levels.  
Moreover large neutral amino acids (except tryptophane) were significantly higher in 
patients with cerebral malaria which also agrees with previous studies.149, 156  
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Arginine 
In this study arginine was taken as indicator of NO synthesis. In African children with 
cerebral malaria,18 the mean plasma L- arginine concentration with severe malaria was 
below the half-saturating concentration (Km) of the cationic amino acid transporters (100 
– 150 _ mol/liter). This suggests that hypoargininaemia may limit L- arginine transport 
into cells and consequently NO production. The low L- arginine levels, NOS generates 
superoxide rather than NO, resulting in oxidant-mediated cellular damage leading to NO 
quenching by superoxide and further reducing NO bioavailability. This may contribute to 
the greater endothelial dysfunction found in severe malaria.185, 135  
 
Arginine was expected to be lower in the severe malaria especially in cerebral malaria 
compared with uncomplicated malaria. It has been reported that hypoargininaemia may 
lead to decrease NO production in children which is associated with fatal outcome in 
individuals with cerebral malaria.17, 18  In a controlled prospective study, Anstey136 et  al  
in 1996 noted high NO production and mononuclear cell immunoreactive NOS2 in 
Tanzanian malaria-exposed, healthy control children. NO production and NOS2 
expression were significantly lower in children admitted to hospital with uncomplicated 
malaria and cerebral malaria, than in controls. This finding suggests that high 
concentrations of NO could protect against cerebral malaria.136  
 
In this study, no difference was found in arginine between the severe and uncomplicated 
malaria (P=0.4). Both groups severe and uncomplicated malaria had low mean arginine 
25.63 and 29.79 µmol/l respectively (compared to Lopansri18 in 2003 who found 46 
µmol/l in children and Yeo185 in 2007 who found 49 and 42 µmol/l in adult with severe 
and moderately severe falciparum malaria respectively) which indicates that NO was low 
in these children. A significant difference was found between the severe anaemia and 
uncomplicated malaria p=0.02.  No significant difference was found between cerebral 
malaria and uncomplicated malaria. The amino acids involved in arginine metabolism 
(Citrulline and Ornithine) were also lower in the severe malaria group. This study did not 
show an association of arginine with severity of malaria; except in cases with anaemia. 
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Lopansri et al18 in 2003 measured concentrations of L-arginine in plasma samples from 
Tanzanian children with and without malaria. L-arginine concentrations were low in 
individuals with cerebral malaria, intermediate in those with uncomplicated malaria, and 
within the normal range in healthy controls. Plasma L-arginine concentrations were 
inversely associated with severity of malaria in Tanzanian children.18 Hypoargininaemia 
may complicate malaria through contribution to limiting NO production in both children 
with severe and uncomplicated malaria. Implications of this finding may reflect on 
immunity and some of the manifestation of severe malaria especially these due to 
vascular, renal changes and sequestration of RBCs.120  
 
In vitro, NO reduces the expression of cytokine-inducible adhesion molecules on 
endothelial cells186 and decreases cytoadherence of parasitized erythrocytes to the 
microvascular endothelium. Impaired in vivo endothelial NO production in malaria is 
likely to exacerbate this processes.140  
 
Patients with sickle cell disease and vaso-occlusive syndrome, and patients with lysuric 
protein intolerance (an inherited disease of L-arginine deficiency due to mutations in 
cationic aminoacid transporters) have endothelial dysfunction that is related to 
hypoargininaemia and reduced NO production. L-arginine therapy restores NO 
production in sickle cell disease and lysuric protein intolerance, and endothelial function 
in lysuric protein intolerance.187, 185 Endothelial dysfunction in malaria is nearly 
universal in severe disease, is reversible with arginine, and likely contributes to its 
pathogenesis.185  
 
Possible causes of hypoargininaemia in SM include decreased l- arginine synthesis and 
increased catabolism caused by the increased activity of plasma arginase and/or cytokine-
inducible arginase in endothelial cells or immune cells, processes that may also occur in 
other inflamatory conditions. As well as impairing endothelial function, 
hypoargininaemia and NO deficiency may contribute to pathology in SM through other 
mechanisms. NO inhibits platelet activation,185 and deficiency may therefore exacerbate 
platelet mediated processes linked to the microvascular pathology of SM, including 
endothelial cell activation188 and apoptosis and platelet-mediated clumping.189 Because 
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NO is also a determinant of red cell deformability, deficiency of NO may exacerbate the 
impaired red cell deformability found in severe malaria,190 further compromising 
microvascular perfusion. 
 
Arginine concentrations may be decreased by increased arginase 1 and 2 activity (with 
formation of ornithine and urea), increased NO synthesis by isoforms of the enzyme NO 
synthase (with formation of NO and citrulline), or secondary to decreased endogenous de 
novo arginine synthesis from citrulline in the proximal renal tubule, which is a major 
pathway for the maintenance of plasma arginine concentrations. 120 Taken together with 
the low arginine levels citrulline was significantly lower in severe malaria cases which 
can be interpreted to indicate low NO synthesis in the severe malaria group. Gramaglia191   
et al in 2006 could recently show that low NO bioavailability contributes to the genesis of 
murine cerebral malaria and mice treated with exogenous NO did not develop severe 
malaria.191 Although there are limited data on plasma amino acid concentrations in 
critically ill children, our results are supported by studies that have reported low arginine 
concentrations in other childhood diseases associated with inflammation,120  sickle cell 
disease,117 and asthma during acute exacerbations. 122  
 
Dietmann192 et al in 2008 studied both endothelin-1 (ET-1) and C-type natriuretic peptide 
(CNP) in Gabonese children with severe and uncomplicated falciparum malaria. Plasma 
levels of ET-1 and N-terminal fragments of CNP (NT-proCNP) were studied on 
admission and after 24 hours of treatment, using enzyme-linked-immunosorbent-assay 
(ELISA). An imbalance between the vasoconstricitve and vasorelaxant endothelium-
derived substances ET-1 and CNP in the plasma of children with falciparum malaria is 
demonstrated, presumably in favor of vasoconstrictive and pro-inflammatory effects. 
This may indicate involvement of ET-1 and CNP in malaria pathogenesis. The 
preponderance of vasoconstrictive effects may not only be due to elevated ET-1 and 
decreased CNP levels, but also indirectly via impaired endothelial nitric oxide (NO) 
production. Furthermore, results of lower ET-1 and CNP levels in severe malaria may 
reflect endothelial cell damage. 192 
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Ramzy193 et al in 2006 were able to establish a link between ET-1 and NO production, 
which high levels of ET-1 impair endothelial NO production via an isoform-specific 
PKC-mediated inhibition of eNOS expression. 193 As circulating PRBCs do not reflect 
the degree of endothelial cell activation and PRBC sequestration in the microvasculature, 
the decreasing ET-1 levels in severe malaria patients could indirectly represent inhibition 
of endothelial ET-1 production by sequestered PRBCs. 194  
Citrulline 
Citrulline is a nonessential amino acid, which means that it is manufactured from other 
amino acids in the liver. Citrulline is a precursor to arginine and is involved in the 
formation of urea in the liver. Also it is necessary to help detoxify ammonia and convert 
it to urea. Citrulline was significantly lower P=0.01 in the severe malaria group ( 9.8 
µmol/l) compared with uncomplicated malaria (18.25µmol/l). But no significant 
difference was found between categories of severe malaria and uncomplicated malaria. 
Low arginine concentrations were also associated with low citrulline concentrations 
which suggest that decreased citrulline availability for arginine production in the kidney 
may play a role in the genesis of arginine depletion in this study. As severe malaria 
children had significantly lower citrulline compared with these with uncomplicated 
malaria, they are more susceptible to hypoargininaemia. 
 
Waardenburg120 and et al in 2007 investigated plasma arginine and citrulline 
concentrations in critically ill children and concluded that plasma concentrations of 
arginine and citrulline are low during the acute phase of critical illness in children and 
normalize again during recovery. Plasma arginine and citrulline are strongly related to the 
severity of inflammation120  It may be conclude that hypoargininaemia discovered in this 
study may not be specific to malaria but as a result of the body response to infection and 
in proportion to it. 
 
Ornithine:  
Ornithine was lower in the severe malaria group (26 µmol/l) compared with 
uncomplicated malaria (37.16 µmol/l) although it did not reach a statistical difference 
P=0.07. Ornithine is necessary for a healthy immune system; detoxifies ammonia, 
stimulates insulin secretion and helps insulin work as an anabolic (muscle building) 
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hormone. The low Ornithine mean level may probably causes the low insulin in the 
severe malaria group (5.31ng/ml) compared with the uncomplicated malaria 8.59 
ng/ml. 
 
Phenylalanine 
The mechanism by which hyperphynelalaninemia develops in acute infections has not 
been established. Release of phenylalanine into the circulation from skeletal muscle 
catabolism may be an important factor. Under normal circumstances, excess 
phenylalanine leads to substrate-level regulation of hepatic phenylalanine hydroxylase 
activity with consequent lowering of plasma Phenylalanine levels within a narrow range 
(40 to 84 µmol/l). This enzyme converts phenylalanine to tyrosine in an oxygen- and 
pterin-dependent reaction.17 The causes and sequelae of chronic hyperphenylalaninemia 
have been well characterized in children with inborn errors of phenylalanine metabolism. 
However, less is known about the physiologic consequences of acute perturbations in 
phenylalanine metabolism, especially in infectious diseases.17  
 
Hyperphenylalaninemia in children with falciparum malaria have been observed in two 
previous studies (Lopansriet al17 in 2006 and Enwonwu et al149 in 1999) in which 
children with cerebral malaria had elevated phenylalanine concentrations. Malaria 
elicited significantly elevated plasma levels of phenylalanine, particularly in comatose 
patients. 
 
Severe malaria cases in this study had significantly higher mean level phenylalanine 
(90.5 µmol/l) with p value=0.01, leading to significant hyperphynelalaninemia 
particularly in comatose patients (112.3 µmol/l for cerebral malaria and 113 µmol/l 
hypoglycaemic patients), and convulsions patients (85.03 µmol/l). Suggesting an 
impaired phenylalanine hydroxylase enzyme system in severe malaria infection. 
 
Maintenance of plasma phenylalanine homeostasis is disrupted in severe malaria, leading 
to significant hyperphenylalaninemia. This is likely a result of an acquired abnormality in 
the function of the liver enzyme phenylalanine hydroxylase. Determination of the 
mechanism of this abnormality may contribute to the understanding of neurological 
complications in malaria.149  
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 Hyperphenylalaninemia in malaria may have important patho-physiologic consequences. 
Two examples come from inborn errors affecting aromatic amino acid metabolism (e.g., 
phenylketonuria and dopamine-responsive dystonia [DRD] that lead to neurological 
abnormalities. These genetic diseases impair phenylalanine hydroxylase activity by 
different mechanisms, and both cause chronic neurological disease in children. 
Phenylketonuria is due to inherited mutations in the phenylalanine hydroxylase gene that 
lead to persistent elevations in plasma phenylalanine levels up to 50 times greater than 
normal. High concentrations of plasma phenylalanine lead to Phenylalanine accumulation 
in the brain, which is neurotoxic.17, 195 However, the levels reported during attack of 
severe malaria (cerebral malaria) are far lower than these inborn errors. The degree of 
hyperphenylalaninemia observed in malaria does not compare with the extreme 
elevations seen in phenylketonuria. This may explain the transient CNS signs which seem 
to be completely reversible. 17  
 
Amino acids in the Three Main Categories of Severe Malaria 
Severe anaemia: 
Severely anaemic patients, who represent the younger age group in this study (3.4years), 
had significantly lower arginine mean level 19.30µmol/l and significantly lower urea 
compared to the other categories. Most of the amino acids were consistently lower in this 
group. Also, in severe anaemia Threonine, Alanine, Valine, Leucine, Lysine, Arginine 
and Ornithine were significantly lower compared to uncomplicated malaria. All of theses 
amino acids are essential except for Ornithine; an observation suggestive of protein-
energy malnutrition in a good number of the children {weight-for-age (WAZ), height-for-
age (HAZ), and weight-for-height (WHZ) Z-scores were not done in this study and are 
highly recommended in future studies}. Severe anaemia in this study was not associated 
with CNS complication, paradoxically anaemia seem to protect against CNS 
cmplications. 
Plasma amino acid abnormalities characterize several health conditions including protein 
energy malnutrition, infections, severe trauma, and stress, as well as sepsis.149 
Malnutrition in this group of children is a possible cause of severe anaemia. 
Arginine amino acid: Among the clinical categories of severe malaria, the severe anaemia 
group showed significantly lower mean of arginine amino acid. Hypoargininaemia in the 
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severe malaria patients may be due to increased arginase activity from ruptured 
erythrocyte.  Erythrocyte rupture results in increased cell-free hemoglobin and plasma 
arginase, leading to increased NO consumption and plasma L-arginine catabolism, 
respectively, and an overall reduction in NO bioavailability. In sickle cell disease, these 
mechanisms are thought to contribute to endothelial dysfunction and mortality.117 
Because hemolysis is found in malaria, these processes may also contribute to NO 
deficiency, endothelial dysfunction, and pathogenesis in severe malaria; however, human 
studies on this point are lacking.185  
Severe anaemia is a more common complication of P. falciparum malaria in hospitalized 
Zambian children 9.5% of paediatric admissions. Malnutrition and changes in immune 
response patterns due to prolonged exposure to P. falciparum may contribute to the 
development of this complication. Severe anaemia is correlated strongly with the degree 
of parasitaemia, and malnutrition.76 In northern Ghana, severe anemia was associated 
with young age, malnutrition, and hyperlactatemia, but not with hyperparasitemia. In 
Tanzanian children parasitemia outweighed malnutrition as a cause of severe 
anaemia.196,197  
Lysine amino acid: Lysine (lys) was significantly lower in the severe malaria group than 
uncomplicated malaria. On comparison of the clinical categories of severe malaria with 
uncomplicated malaria, only severe anemiac patients showed the significantly lower 
mean lysine levels. Lysine deficiency may present with symptoms of anaemia, enzyme 
disorders, weight loss, and poor appetite. 
 
Convulsions: 
Seizures are common in falciparum malaria, prolonged and multiple seizures are 
associated with neurological sequelae. Seizures may be a marker of neurological damage 
rather than the cause. The seizures may be caused by intracranial sequestration of 
metabolically active parasites or "toxins" produced by the parasites. This phenomenon 
seems to be mediated by plasmodium derived proteins on the surface of PRBCs and 
modified erythrocyte cell wall proteins and ligands on endothelial cells. The adhesion of 
the PRBCs reduces the microvascular blood flow.24 It is note worthy that amino acids 
level in patients with convulsions were close to levels found in cases of uncomplicated 
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malaria with the exception of Phenylalanine which showed significantly higher levels 
(85.03µmol/l) compared with uncomplicated malaria P value= 0.03. Another observation 
worth noting is that cases with convulsions showed significantly lower mean Hb levels P 
value= 0.02 (7.39 g/dl) than the cases of cerebral malaria which may suggest anaemic 
hypoxia as a possible contributor to convulsions in this group.  The mechanism of 
convulsions may be different from that of cerebral malaria and is in someway related to 
low Hb.  
Cerebral malaria: 
Large neutral amino acids: Large neutral amino acids circulating in blood plasma are 
precursors for brain synthesis of the monoamines such as serotonin, histamine, and 
catecholamines. Alternation in their concentration or turnover in the brain could affect 
monoaminergic function. Altered brain levels of monoamines resulting primarily from 
imbalance in blood levels of the relevant precursor amino acids, could explain aspects of 
the cerebral complications of severe falciparum malaria in humans. Disorders of central 
monoamine metabolism may underlie the pathogenesis of metabolic encephalopathies.149  
Also Shulkin 150 et al in 1995 had found that, the delivery of large neutral amino acids 
(LNAAs) across the blood-brain barrier (BBB) is mediated by the L-type neutral amino 
acid transporter present in the membranes of the brain capillary endothelial cell. In 
experimental animals, the L-system transporter is saturated under normal conditions, and 
therefore an elevation in the plasma concentration of one LNAA will reduce brain uptake 
of other LNAAs across the human BBB. 150 
In this study large neutral amino acids were significantly higher in cerebral malaria 
patients {Valine (Val), Methionine (Met), Histidine (His), Isoleucine (Ile), 
Phenylalanine (Phe) , Tyrosine (Tyr), Tryptophane (Trp),  Leucine (Leu), except  for 
Tryptophane} compared with uncomplicated malaria. However, Taurine and Glycine 
were also significantly higher in cerebral malaria than uncomplicated malaria. 
 
Recent studies showed that malaria caused a marked increase in plasma histidine with 
elevation in histamine, as well as an increase in plasma phenylalanine with no changes 
in other LNAA.156 Brain monoamine levels may underlie aspects of the cerebral 
component of falciparum malaria149, 156  Enwonwu149 et al in 1999 measured LNAAs 
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in malaria patients and controls. They found that malaria elicited significantly elevated 
plasma levels of phenylalanine, particularly in comatose patients and altered brain 
uptake of phenylalanine, Tryptophane and Histidine with no effect on Tyrosine, 
compared with control findings. Their data suggest impaired cerebral synthesis of 
serotonin, dopamine and norepinephrine, and enhanced production of histamine, in 
children with severe falciparum malaria. 
 
In conclusion of the discussion section, the most significant findings in this study were: 
Random blood glucose levels were nearly the same in severe and uncomplicated malaria 
patients and within the normal physiological range. However incidence of 
hypoglycaemia cannot be ruled out. The mean of insulin: C-peptide ratio was 
significantly lower in severe malaria which indicating decreased half-life of insulin in 
patients with severe malaria. Decreased insulin together with the normal RBG, this 
suggests increased liver uptake which impair gluconeogenesis and therefore high levels 
of amino acids in the blood. Few studies are required for the study of insulin turnover 
and in particular it's handling by the liver in severe malaria. An animal model may be 
more suitable for this purpose. 
 
 L-arginine and citrulline concentrations were low in individuals with severe and 
uncomplicated malaria; a finding suggestive of reduced NO production with its 
consequences on endothelial pathology. Also, phenylalanine was significantly higher in 
severe malaria patients than uncomplicated malaria patients. Large neutral amino acids 
(except Tryptophane) were significantly higher in patients with cerebral malaria which 
suggest impaired cerebral synthesis of monoamines. It is also worth noting that most of 
the children were hypokalaemic at the time of admission.  
 
These findings will hopefully shed some light on the pathophysiology of malaria as well 
as pointing to parameters which will helps avoid the severe complications and fatal 
outcome, such as potassium and urea which we believe it should be measured on 
admission. Feasibility of monitoring some amino acids such as phenylalanine and 
arginine need to be considered so as to identify predictors of CNS involvement and 
therefore reduce it incidence.  
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Conclusions 
 
Age Distribution  
 
- Severe malaria affected children mainly less than five years old. 
- Convulsions and severe anaemia occurred in the younger age group. 
- Cerebral malaria occurred in the older age group. 
- The difference in the age distribution of the different complications has special 
importance as a risk indicator. 
 
Glucose Homeostasis 
 
Blood glucose 
- Most children with severe malaria (95.6%) were normoglycaemic on admission.  
- Random blood glucose levels were within the normal physiological range and nearly 
the same in severe and uncomplicated malaria patients. 
- Hypoglycaemia was an uncommon complication; it was found only in two patients, 
who represent 4.4% of patients with severe malaria. 
- Blood glucose levels were not related to any of the other complications of severe 
malaria.  
 
Glucogenic amino acids 
- No significant difference was found between the mean values of children with severe 
malaria and uncomplicated malaria in glucogenic plasma amino acid levels which 
suggests unimpaired gluconeogenesis. 
- Patients with cerebral malaria had high incidence of increased glucogenic amino acids 
associated with normal RBG which suggest unimpaired gluconeogenesis. In 
Hypoglycaemic patients the high incidence of glucogenic amino acids was associated 
with low RBG which suggests impaired gluconeogenesis. 
-Alanine was significantly higher in the two patients with hypoglycaemia compared with 
the other categories of severe malaria. This may be due to impaired hepatic 
gluconeogenesis in these two patients. 
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Insulin and C-peptide 
 
- Plasma insulin levels were significantly low in the severe malaria group (5.31 mlU/ml) 
compared with uncomplicated malaria (8.59 mlU/ml) but no difference was found in C-
peptide levels. 
- Hypoglycaemic patients did not have hyperinsulinaemia as reported in other studies. 
- The incidence of hypoinsulinaemia was significantly higher in children with severe 
malaria. 
- The mean of Insulin: C-peptide ratio was significantly lower in severe malaria 
compared with uncomplicated malaria suggesting a decreased half- life of insulin. 
 
Potassium 
- Potassium levels were low in all patients studied, and there was no significant 
difference between the mean values in severe and uncomplicated malaria. However, the 
patients with anaemia and cerebral malaria had significantly higher incidence of 
hypokalaemia.  
 
Blood Urea Nitrogen (BUN) 
- There was no significant difference between the BUN levels of severe and 
uncomplicated malaria patients.  
- Severely anaemic patients had significantly lower level of BUN compared with the 
other categories of severe malaria. 
- High levels of urea were found in both cases with fatal outcome. 
 
Amino acids in Severe and Uncomplicated Malaria 
Arginine  
- Arginine concentrations were low in individuals with severe and uncomplicated 
malaria.  
 
Citrulline  
- Citrulline was significantly lower in the severe malaria cases which may indicate 
lower NO synthesis when taken together with hypoarginaniaemia. 
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Phenylalanine  
- Phenylalanine was significantly higher in severe than uncomplicated malaria 
patients; in particular those with cerebral malaria. This may be due to deficiency of 
phenylalanine hydroxylase enzyme in the liver. 
 
Amino acids in various categories of severe malaria 
Severe anaemia 
-Most of the amino acids were consistently lower in patients with anaemia.  
-Patients with anaemia had lower levels of arginine than all other patients. 
 
Cerebral malaria 
 -In patients with cerebral malaria there was highly significant hyperphynelalaninemia. 
 
- Large neutral amino acids (except Tryptophane) were significantly higher in patients 
with cerebral malaria. 
 
Convulsions 
- Children who had convulsions did not show any significant difference in the mean of 
amino acids except for Phenylalanine which was significantly higher; but not to the 
extent found in cerebral malaria. 
- The mechanism of convulsions may be different from that of cerebral malaria and is in 
someway related to the large neutral amino acids which were not elevated to the same 
degree as in cerebral malaria. 
 
Taken together these results give preliminary indications that the different complications 
of severe malaria are associated with specific pathophysiological responses. An 
observation which makes it more pressing to identify warning signs on admission and 
treat each patient according to these indicators.     
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Recommendation 
 
• There are practical difficulties in obtaining a fasting blood sample for glucose, 
insulin, and C-peptide to elucidate their physiological relationships. An animal 
model may serve this purpose. 
 
• The low potassium levels are a danger signal therefore all malaria cases should be 
monitored for serum potassium.  
 
• Only the two cases with a fatal outcome had high blood levels of BUN. It is 
recommended that all cases with severe malaria get a blood urea nitrogen test on 
admission. 
 
• There is a need to establish standards for amino acid levels in normal children in 
Sudan. Further studies of amino acids should take into consideration the 
nutritional status of children with severe malaria. 
 
• Amino acid studies are recommended to further examine their involvement in 
severe malaria. We suggest pre and post treatment measurements especially in 
cases with CNS involvement. 
 
• A battery of blood tests for renal functions, serum potassium, blood glucose and 
some of the amino acids particularly phenylalanine may well be a good point to 
start. 
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University of Khartoum 
Faculty of Medicine  
Department of Physiology 
The Pathophysiology of Severe Malaria  
 
Data Collection Form  
 
Patient's  Data 
Date: …………………………………..……. Code:  
Hospital: ………………………………………………………………………….. 
Name:…………………………………………………………………….………... 
Age: ….……………………………………………………………….…………… 
Residence:…………………………………………………………………………. 
Gender: ………………………………………………………………….………… 
Tel: …………………………………………………………………….………….. 
Present Complain  
1-  Fever:    Duration  
 
2-  Rigor     
 
3- Vomiting:    How many times  
 
4- Diarrhea:    How many times  
 
5-  Anorexia:     
 
6-  Abdominal pain:     
 
7-  Myaligia:     
 
8-  Chest pain:     
 
9-  Artheralgia:     
 
10-  Backache:     
 
11- Dizzness:     
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12 – Loss of consciousness:   How many times  
 
History of present complaint  
13: Time of onset:   
 
14- duration of symptoms of severe malaria     
 
15- Dietary intake day past 24 hours :                     Solid food   
                                                                             Liquid diet  
                                                                                  fluids  
Past History: 
16: Previous attack of Malaria: Yes  No
 
17: Other disease: Yes  No
 
Clinical Examination  
18: Shortness of breath:  
 
19: Blood Pressure:  
 
20: Pulse rate:  
 
21: Temperature :  
 
22:Restlessness:  
 
23: Agression:  
 
24: Aggitation:  
 
25: Jaundice:  
 
26: Convulsions:  
 
 
Systems Examinations 
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R S: Breathing rate ……………. 
Breath sound ……….….…… 
Lung pescussion …….……  
X-ray 
Others   
………….…… 
……….……… 
G I T: Liver ………………………. 
Spleen …………………….. 
Ascites………………… 
Flatulauce 
Abd. Sounds 
Others  
……………… 
……………… 
……………… 
G U: 
……………………………………………………………………. 
……………………………………………………………..……… 
 
CNS: ……………………………………………………………………. 
……………………………………………………………..……… 
M S: 
……………………………………………………………………. 
……………………………………………………………..……… 
 
Bleeding Disorder: 
Bleeding gums ……………….   Sclera …………… 
Subcutaneous  ……………….   Others …………. 
 
Lab Investigation:  
Blood sample:  Time: ………………..  Time of last meal …………………… 
   Date: ………………     Fluid intake ……………………….. 
- BFFM 
Thin ……………………………………………………………………….. 
Thick ……………………………………………….……………………… 
- RBG……………………………………………….……………………...... 
- HB………………………………………….……………………….……… 
- Potassium 
-  
Clinical follow up outcome:  
• …………………………………...…………………………………………… 
• ………………………………………………………………………………… 
• ………………………………………………………………………………… 
• ………………………………………………………………………………… 
 
 
Treatment on Admission: 
Medicine………………………  Time/ Date ……………….……………………… 
Fluids ………………………...   Time/ Date ………………………………………. 
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APPENDIX (II) 
Buffer composition  
 
 
 
 
 
Buffer A Buffer B Buffer C Regeneration 
solution D 
Sample 
dilution 
buffer 
pH value 2.9 4.2 10.5  2.2 
LiCl  4.2g 4.2g   
LiOH*H2O 5.04g 8.4g 8.4g 21.0g 5.04g 
Boric acid   2.5g   
Ethanol 50ml     
Hydrochloric 
acid 32% 
9.0 ml 10 ml 1.5 ml  10 ml 
EDTA    0.4  
Citric acid 15g 15g 10g  16g 
Octanoic 
acid 
0.1 ml o.1 ml l0.1ml  0.1 ml 
